Cellular and molecular aspects of the anti-inflammatory effects of low-dose radiation therapy by Large, Martin
    
Cellular and molecular aspects of  
the anti-inflammatory effects of  
low-dose radiation therapy 
 
   
 Doktorarbeit 
Martin Large 
Biologie 
 
 
Vom Fachbereich Biologie der Technischen Universität Darmstadt 
Zur Erlangung des akademischen Grades 
eines Doctor rerum naturalium  
genehmigte Dissertation von 
 
Dipl. Biologe Martin Large 
 
aus Heidelberg, Deutschland 
 
1. Gutachter: Prof. Dr. Franz Rödel 
2. Gutachter: Prof. Dr. Markus Löbrich 
3. Gutachter: Prof. Dr. Bodo Laube 
 
Tag der Einreichung: 19.06.2015 
Tag der mündlichen Prüfung: 21.09.2015 
 
Darmstadt 2015 
D17 
  
 The present dissertation was performed within the scope of the EU project: Low-dose 
Research towards Multidisciplinary Integration (DoReMi). Project grant agreement 
number: 249689. 
 
Results were in part published in: 
 
Large M, Reichert S, Hehlgans S, Fournier C, Rödel C, Rödel F (2014).  
A non-linear detection of phospho-histone H2AX in EA.hy926 endothelial cells following 
low-dose X-irradiation is modulated by reactive oxygen species.  
Radiation Oncology 9(1), 80. 
 
Large M, Hehlgans S, Reichert S, Gaipl US, Fournier C, Rödel C, Weiss C, Rödel F 
(2015).  
Study of the anti-inflammatory effects of low-dose radiation: The contribution of biphasic 
regulation of the antioxidative system in endothelial cells.  
Strahlenther Onkol. Epub ahead of print.  
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
So eine Arbeit wird eigentlich nie fertig, man muss sie für fertig erklären, 
wenn man nach Zeit und Umständen das möglichste getan hat. 
 
Johann Wolfgang von Goethe 
 
 
 
 
  
 Word of honour I 
Word of honour 
I assure herewith on my word of honour, that I wrote this thesis by myself. All quotes, 
whether word by word, or in my own words, have been put in quotation marks or 
otherwise identified as such. The thesis has not been published anywhere else or has 
been presented to any other examination board. 
 
 
___________________________ 
Martin Large 
 
Darmstadt, 25. September 2015 
 
 Contents II 
Contents 
Word of honour .......................................................................................................... I 
Contents ..................................................................................................................... II 
List of Figures .......................................................................................................... IV 
List of Tables ............................................................................................................ V 
Summary/Zusammenfassung .................................................................................. 1 
1. Introduction ........................................................................................................ 5 
1.1 ...... Low-dose radiation therapy ..................................................................................... 5 
1.2 ...... Inflammation ............................................................................................................ 6 
1.3 ...... Molecular mechanisms of low-dose radiation therapy.............................................. 9 
1.4 ...... DNA damage response in eukaryotic cells ............................................................ 12 
1.4.1 Primary damage recognition and signal transduction ...................................... 13 
1.4.2 DSB repair mechanisms ................................................................................. 14 
1.5 ...... Oxidative stress response ..................................................................................... 15 
1.6 ...... Aim of the project .................................................................................................. 18 
2 Material and methods ...................................................................................... 19 
2.1 ...... Material ................................................................................................................. 19 
2.1.1 Appliances ...................................................................................................... 19 
2.1.2 Consumables.................................................................................................. 20 
2.1.3 Chemicals and media ..................................................................................... 21 
2.1.4 Buffers and solutions ...................................................................................... 22 
2.1.5 Antibodies ....................................................................................................... 25 
2.1.6 Primers and probes for real-time PCR ............................................................ 26 
2.1.7 Commercial Kits ............................................................................................. 27 
2.1.8 Cells ............................................................................................................... 28 
2.2 ...... Methods ................................................................................................................ 28 
2.2.1 Cell culture and stimulation ............................................................................. 28 
2.2.2 Freezing and thawing of cells ......................................................................... 28 
2.2.3 Cell lysis ......................................................................................................... 29 
2.2.4 Determination of protein concentration ........................................................... 29 
2.2.5 SDS-PAGE/western immunoblotting ............................................................... 29 
2.2.6 SOD activity assay.......................................................................................... 30 
2.2.7 Catalase activity assay ................................................................................... 30 
2.2.8 Glutathione peroxidase activity assay ............................................................. 31 
2.2.9 Subcellular fractionation ................................................................................. 31 
2.2.10 Nrf2 DNA-binding activity assay...................................................................... 32 
2.2.11 mRNA isolation ............................................................................................... 32 
2.2.12 cDNA synthesis .............................................................................................. 33 
2.2.13 Real-time PCR ................................................................................................ 33 
2.2.14 Isolation and biotinylation of PBMC ................................................................ 33 
 Contents III 
2.2.15 Adhesion Assay .............................................................................................. 34 
2.2.16 Immunofluorescence staining ......................................................................... 35 
2.2.17 Flow cytometry ............................................................................................... 36 
2.2.18 Irradiation ....................................................................................................... 37 
2.3 ...... Data analysis ......................................................................................................... 37 
3 Results .............................................................................................................. 38 
3.1 ...... Time and dose kinetics of H2AX foci after low-dose radiation .............................. 38 
3.2 ...... H2AX foci after low-dose radiation and inhibition of DNA damage repair ............. 40 
3.3 ...... Levels of reactive oxygen species after low-dose radiation ................................... 42 
3.4  H2AX foci after low-dose radiation and scavenging of reactive oxygen species 
by N-acetyl-cysteine .............................................................................................. 44 
3.4.1 Analysis of the antioxidative defence mechanisms after low-dose radiation .... 45 
3.4.2 Modulation of Nrf2 expression and DNA-binding activity ................................. 50 
3.5 ...... Functional analysis ................................................................................................ 52 
3.5.1 Adhesion after scavenging of reactive oxygen species by N-acetyl-cysteine 
and low-dose radiation .................................................................................... 52 
3.5.2 Adhesion after indirect activation of Nrf2 and low-dose radiation .................... 54 
4 Discussion ........................................................................................................ 57 
5 References ....................................................................................................... VII 
6 Appendix ....................................................................................................... XXIII 
Own work ............................................................................................................. XXIV 
Acknowledgements .............................................................................................. XXV 
Curriculum Vitae .................................................................................................. XXVI 
List of Abbreviations ......................................................................................... XXVIII 
 
 List of Figures IV 
List of Figures 
Figure 1. Scheme of leukocyte adhesion to endothelial cells, an initial step in the 
inflammatory cascade ................................................................................................. 8 
Figure 2. Current model of immunomodulatory effects of low-dose radiation (< 1 Gy) on 
cells of the immune system ...................................................................................... 11 
Figure 3. DNA double-strand break signalling pathways and cellular radiation response ..... 13 
Figure 4. Major pathways of reactive oxygen species generation and detoxification ............ 17 
Figure 5. Scheme of adhesion assay ................................................................................... 34 
Figure 6. Dose and time kinetics of H2AX foci in EA.hy926 EC following low-dose X-
irradiation ................................................................................................................. 39 
Figure 7. H2AX foci levels in EA.hy926 EC following low-dose X-irradiation in the 
presence of inhibitors for NHEJ and HR ................................................................... 41 
Figure 8. ROS levels in EA.hy926 ECs following low-dose X-irradiation .............................. 43 
Figure 9. H2AX foci levels in EA.hy926 EC following low-dose X-irradiation in the 
presence of the ROS scavenger NAC ...................................................................... 44 
Figure 10. SOD1 protein expression and SOD activity in EA.hy926 ECs following low-
dose X-irradiation ..................................................................................................... 46 
Figure 12. SOD1 mRNA expression levels in EA.hy926 cells following low-dose X-
irradiation ................................................................................................................. 49 
Figure 13. Nrf2 protein expression and DNA-binding activity in EA.hy926 cells following 
low-dose X-irradiation ............................................................................................... 51 
Figure 14. Adhesion of PBMC to TNF-α stimulated EA.hy926 ECs following low-dose X-
irradiation in the presence or absence of NAC .......................................................... 53 
Figure 15. Adhesion of PBMC to TNF-α stimulated EA.hy926 ECs following low-dose X-
irradiation in the presence of AI-1 or DMSO ............................................................. 55 
Figure 16. Scheme of isolated or clustered DSB (Local Effect Model) and proposed model 
for the origination of a non-linear dose-response ...................................................... 60 
Figure 17. Advanced model on factors involved in the anti-inflammatory effect of low-dose 
irradiation therapy ..................................................................................................... 65 
Supplementary Figure 1. Dose and time kinetics of H2AX foci levels in EA.hy926 EC 
following low-dose X-irradiation divided into G1 and G2 phase .............................XXIII 
 List of Tables V 
List of Tables 
Table 1. Pipetting scheme for discontinuous SDS-electrophoresis gels (8.3 cm x 7.3 cm x 
1 mm) ....................................................................................................................... 24 
Table 2. Primary antibodies used for immunofluorescence, flow cytometry and western 
immunoblotting ......................................................................................................... 25 
Table 3. Secondary antibodies used for immunofluorescence and flow cytometry ............... 25 
Table 4. Secondary antibodies used for western immunoblotting ......................................... 26 
Table 5. Forward/reverse primers and probes used for real-time PCR ................................. 26 
Table 6. Inhibitors and Activators ......................................................................................... 27 
Table 7. Kits used for activity analysis ................................................................................. 27 
Table 8. Protein determination, RNA isolation and subcellular fractionation kits................... 27 
 Summary/Zusammenfassung 1 
Summary/Zusammenfassung 
For decades an anti-inflammatory and analgesic effect of low-dose X-irradiation (LD-RT) 
has clinically been well established in the treatment of a plethora of benign diseases and 
chronic degenerative disorders with empirically identified single doses < 1 Gy to be most 
effective. Although considerable progress has been achieved in the understanding of 
immune modulatory effects of ionising radiation, especially in the low-dose range, the 
underlying molecular mechanisms are currently not fully resolved. Nevertheless, a 
modulation of endothelial cell (EC) activity has already been proven to comprise a key 
element in the therapeutic effects of LD-RT. In line with that, a putative interrelationship 
between DNA damage repair and a discontinuous dose-response relationship following 
low-dose irradiation was recently suggested. Moreover, a mechanistic involvement of 
reactive oxygen species (ROS) production and the cellular antioxidative response to give 
rise or contribute to these phenomena in endothelial cells remain elusive. Thus, in the 
present study, radiation effects with a particular focus on low-dose irradiation of ECs were 
investigated. 
To analyse DNA repair capacity, phospho-histone H2AX foci were assayed at 1 h, 4 h and 
24 h after irradiation. ROS production, superoxide dismutase (SOD), catalase (CAT), 
glutathione peroxidase (GPx) and transcription factor nuclear factor E2-related factor 2 
(Nrf2) expression and activity were analysed by western immunoblotting, fluorometric 
2',7'-dichlorodihydrofluorescein-diacetate (H2DCFDA), colorimetric assays, flow-cytometry 
and real-time PCR, respectively. A functional impact of ROS on H2AX foci numbers and 
on peripheral blood mononuclear cell (PBMC) adhesion to ECs was assayed in the 
presence of the ROS scavenger N-acetyl-L-cysteine (NAC) and the Nrf2 activator AI-1.  
Irrespective of inflammatory stimulation by tumour necrosis factor-α (TNF-α), immortalised 
EA.hy926 ECs cells revealed a linear dose-response characteristic of H2AX foci levels at 
1 h and 4 h after irradiation. By contrast, at 24 h after irradiation a discontinuity in residual 
H2AX foci levels with locally elevated values following a 0.5 Gy exposure were observed. 
This effect was unlikely caused by modulation of DNA damage repair, as proven by small 
molecule inhibitors targeting either the repair pathways homologous recombination (HR) 
or non-homologous end joining (NHEJ). However, the discontinuity in H2AX foci levels 
was abolished by treatment with N-acetyl-L-cysteine (NAC), indicating an involvement of 
ROS. In line with that, in EA.hy926 ECs a discontinuous expression and enzymatic activity 
of SOD, CAT and GPx concomitant with a lowered expression and DNA-binding activity of 
the redox sensitive transcription factor Nrf2 most pronounced after a dose of 0.5 Gy was 
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observed. Finally, scavenging of ROS by NAC or activation of Nrf2 by AI-1 significantly 
diminished a lowered adhesion of PBMC to EC, typically detectable following irradiation 
with a dose of 0.5 Gy 
In conclusion, these results indicate a non-linear regulation of ROS production, major 
compounds of the antioxidative system including SOD, CAT, GPx and Nrf2 expression 
and activity in EA.hy926 EC following irradiation with doses < 1 Gy. This functionally 
contributes to a discontinuous level of residual H2AX foci and a hampered leukocyte/EC 
adhesion. These data may thus contribute a further component to the plethora of 
mechanisms implicated in the anti-inflammatory effects of low-dose X-ray exposure. 
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Bereits seit Jahrzehnten ist eine niedrig dosierte Röntgenbestrahlung (LD-RT) in der 
Therapie einer Vielzahl von gutartigen und chronisch degenerativen Erkrankungen 
etabliert. Dabei wurden Einzeldosen < 1 Gy empirisch als die am wirksamsten identifiziert. 
Obwohl erhebliche Fortschritte in der Aufklärung der immunmodulierenden Effekte 
ionisierender Strahlung - insbesondere im Bereich niedriger Dosen - erzielt wurden, sind 
die zugrunde liegenden molekularen Mechanismen derzeit nur unzureichend verstanden. 
Nichtsdestotrotz konnte bereits eine Modulation der Aktivität von Endothelzellen als 
entscheidendes Element der therapeutischen Effekte einer LD-RT verifiziert werden. 
Zusätzlich wurde kürzlich ein möglicher Zusammenhang zwischen der DNA-
Schadensreparatur und einer diskontinuierlichen Dosis-Wirkungsbeziehung nach 
Bestrahlung mit niedrigen Dosen entdeckt. Darüber hinaus ist ein Einfluss der Produktion 
reaktiver Sauerstoffmetaboliten (ROS) und der zellulären anti-oxidativen Antwort als 
mögliche Ursache oder Beitrag zu diesen Phänomenen in Endothelzellen bisher 
ungeklärt. Entsprechend wurden in der vorliegenden Arbeit Bestrahlungseffekte in 
Endothelzellen mit Fokus auf eine Niedrigdosis-Bestrahlung untersucht.  
Für die Analyse der DNA-Reparaturkapazität wurden Phospho-Histon H2AX Foci eine, 
vier und 24 Stunden nach Bestrahlung analysiert. Die Produktion von ROS, die 
Expression und Aktivität der Enzyme Superoxid Dismutase (SOD), Katalase (CAT), 
Gluthation-Peroxidase (GPx) und des Transkriptionsfaktors Nuclear Factor E2-related 
Factor 2 (Nrf2) wurden mittels Western Blot, fluorometrischer 2',7'-Dichlorodi-
hydrofluorescein-diacetat (H2DCFDA) Messung, kolorimetrischen Assays, Durchfluss-
zytometrie und quantitativer PCR analysiert. Ein funktioneller Einfluss von ROS auf das 
Level der H2AX Foci und die Adhäsion mononukleärer Zellen des peripheren Blutes 
(PBMC) an EC wurde durch den Einsatz des ROS-Fängers N-Acetyl-L-Cysteins (NAC) 
und des Nrf2-Aktivators AI-1 untersucht.  
Dabei wies die immortalisierte Endothelzelllinie EA.hy926, unabhängig von einer pro-
inflammatorischen Aktivierung durch Tumornekrosefaktor-α (TNF-α), einen lineare Dosis-
Wirkungs-Beziehung an H2AX Foci eine und vier Stunden nach Bestrahlung auf. Im 
Gegensatz dazu konnte 24 Stunden nach einer Bestrahlung, ein diskontinuierliches Level 
an H2AX Foci mit erhöhten Werten nach einer Bestrahlung mit 0,5 Gy beobachtet 
werden. Dieser Effekt wird vermutlich nicht durch eine Modulation der DNA-Schadens-
Reparatur hervorgerufen, wie Versuche mit niedermolekularen Inhibitoren für die 
Reparaturmechanismem homologe Rekombination (HR) und nicht-homologe 
Endverknüpfung (NHEJ) nahelegen. Im Gegensatz dazu konnte die Diskontinuität in der 
Ausprägung der H2AX Foci nach Behandlung mit dem ROS-Fänger NAC aufgehoben 
werden, welches auf eine Beteiligung von ROS an diesem Phänomen hindeutet. 
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Übereinstimmend mit diesen Ergebnissen gelang es, in EA.hy926 Zellen eine nicht-
lineare Expression und enzymatische Aktivität von SOD, CAT und GPx zusammen mit 
einer verringerten Expression und DNA-Bindungsaktivität des redox-sensitiven 
Transkriptionsfaktors Nrf2 mit der höchsten Ausprägung nach einer Bestrahlung mit 
0,5 Gy nachzuweisen. Schließlich führte eine NAC-vermittelte Hemmung von ROS oder 
die Aktivierung von Nrf2 durch AI-1 zu einer signifikanten Aufhebung der typischerweise 
nach Bestrahlung mit einer Dosis von 0,5 Gy beobachteten PBMC/EC-Adhäsions-
minderung. 
Zusammenfassend belegen die Ergebnisse eine nicht-lineare Regulation der ROS-
Produktion und der Expression und Aktivität von Schlüsselelementen des anti-oxidativen 
Systems (SOD, CAT, GPx und Nrf2) in EA.hy926 EC nach Bestrahlungen im 
Dosisbereich < 1 Gy. Auf funktionaler Ebene tragen die erwähnten Effekte zu einem 
diskontinuierlichen Level von H2AX Foci und einer verminderten Leukozytenadhäsion 
bei. Diese Daten tragen somit weitere Komponenten in der Vielzahl der Mechanismen bei, 
die an den anti-inflammatorischen Effekten einer niedrig dosierten Röntgenbestrahlung 
beteiligt sind.  
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1. Introduction 
1.1 Low-dose radiation therapy 
Radiotherapy is recognised as one of the major modalities in the treatment of malignant 
diseases. However, for decades low-dose radiation therapy (LD-RT) of benign disorders 
has been clinically documented to be a valuable treatment option for a multitude of 
degenerative and inflammatory diseases. The first documented clinical application of  
LD-RT was as early as 1898 when Sokolow and Stenbek reported on beneficial effects of 
irradiation of polyarthritis resulting in a reduction in pain and swelling of affected joints 
[1, 2]. 
High radiation doses, commonly used in cancer treatment (single dose > 1 Gy, total dose 
> 30 Gy) are well known to exert pro-inflammatory effects [3], by contrast, low-dose 
exposure (single dose ≤ 1 Gy, total dose ≤ 12 Gy) has been shown to result in anti-
inflammatory efficacy such as inflammatory pain relief, reduced swelling and an 
improvement of angular function [4, 5]. At present, more than 40,000 patients are treated 
with LD-RT per year in Germany which reflects approximately 20% of patients treated with 
radiation therapy [6]. Characteristic clinical indications comprise degenerative or 
inflammatory disorders such as hidradenitis axillaris [7], epicondylitis humeri [8] and 
morbus dupuytren [9]. The doses of radiation and schedules of fractionation mainly derive 
from clinically-empirically investigations by von Pannewitz in the late 1930s [10]. In clinical 
practice, single doses of 0.3–1 Gy distributed in 4–5 fractions for acute or 1–3 fractions for 
chronic inﬂammatory disorders resulting in total doses of 3–5 Gy (acute disease) or  
12 Gy (chronic disease) were applied according to current S2 guidelines [11].  
Several recent clinical investigations evaluating the impact of fractionated treatment with 
either single doses of 0.5 Gy or 1 Gy (total doses 3 Gy or 6 Gy) in three weeks reported 
on iso-effectiveness concerning comprehensive pain score (CPS) and clinical response 
rates in a variety of benign diseases [12, 13]. These trials thus support the hypothesis that 
radiotherapy with a decreased single dose of 0.5 Gy might be equally effective to single 
doses of 1 Gy but markedly decreases total dose and may thus be superior in terms of 
cancerous risk and radiation protection. However, due to very early reports on late harmful 
side effects and an increased mortality from aplastic anaemia and leukaemia in 1965 [14, 
15], LD-RT is considered obsolete in some (Anglo-American) countries. The avoidance 
from LD-RT was further enhanced by the advent and increased availability of effective 
non-steroidal or steroidal drugs displaying lower toxicity. Nevertheless, these alternative 
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treatment options also show considerable numbers of patients with adverse side effects 
and a substantial number of patients do not display sufficient treatment response if at all 
[16]. 
 
1.2 Inflammation 
Inflammation is a uniform response of the immune system to exogenous pathogens, 
endogen noxae, damaged cells or irritants with the aim to eliminate the initial cause of cell 
injury, remove necrotic cells/tissue and initiate the process of tissue repair. Inflammation 
can occur in different forms and modalities which are regulated by diverse mechanisms of 
induction and resolution [17]. Due to a multitude of components and mechanisms 
involved, the inflammatory reaction is a complex process which is regulated on numerous 
levels. A characteristic inflammatory response is divided into four major determinants: 
inflammatory inducers, detecting sensors, mediators and the target tissues which results 
in characteristic clinical symptoms already described in the 1st century AD by Celsus: 
rubor et tumour cum calore et dolore (redness and swelling with heat and pain) [17]. Later 
on, the loss of function was added as the fifth cardinal symptom of inflammation [18]. 
Moreover, inﬂammation is a stereotyped response and therefore considered as a 
mechanism of innate immunity, in contrast to a pathogen speciﬁc adaptive immune 
response [19]. 
A pivotal molecular mechanism in the inﬂammatory process is the secretion of regulatory 
mediators called cytokines by dendritic cells or monocytes/macrophages after sensing an 
infection by pathogens and/or tissue damage. Examples for inflammation promoting 
(proinflammatory) cytokines that activate cellular elements are interferons, interleukin (IL) 
1, 6, 8, 12 and the major key player tumour necrosis factor-α (TNF-α) [20]. By contrast, 
anti-inflammatory cytokines like the isoforms of transforming growth factor β (TGF-β 1–3) or 
IL-10 down-regulate and thus terminate the inﬂammatory cascade [21]. Furthermore, 
proinflammatory cytokines induce a subsequent liberation of chemokines. A broad variety 
of these signal molecules like monocyte chemoattractant protein-1 (MCP1)/chemokine  
(C-C motif) ligand 2 (CCL2) or chemotactic cytokine chemokine (C-C motif) ligand 20 
(CCL20) recruit phagocytic leukocytes (macrophages, monocytes and granulocytes) to 
the place of inflammation [22].  
The local effects of TNF-α at the site of inflammation comprise a dilatation of blood 
vessels (vasodilation) in line with an increased blood flow (redness and heat) and 
increased vascular permeability with a leakage of plasma into the infected tissue (pain 
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and swelling) [23]. In endothelial cells, TNF-α binding to its surface receptors results in an 
increased expression of adhesion molecules like intercellular adhesion molecule 1/2 
(ICAM-1, ICAM-2) and vascular cell adhesion molecule (VCAM-1). This surface marker 
expression is mainly mediated by cytokine-mediated activation of the transcription factor 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B) [24, 25]. With the 
support of additional adhesion molecules like integrins and selectins (E-selectin, P-
selectin) on endothelial cells and their corresponding ligands (e.g. Sialyl-LewisX) 
mononuclear (PBMC) and polymorph nuclear (PMN: granulocytes) leukocytes from 
peripheral blood adhere to the endothelium layer and next extravasate into the tissue [26, 
27]. In more detail, the beginning of this chemotaxis-driven multiphase process is a 
reversible binding of the leukocytes to selectins. While this binding is too weak to persist 
the blood flow, leukocytes and the blood vessels establish and lose the connections for 
several times (rolling adhesion) [28]. This process is followed by a tight binding via  
ICAM-1, ICAM-2 and VCAM-1 to integrins expressed in the endothelial cell layer [29] and 
a subsequent spreading, finally resulting in a movement of the PBMC through the 
endothelium and the basement membrane (diapedesis) into the site of inflammation 
(Figure 1) [30].  
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Figure 1. Scheme of leukocyte adhesion to endothelial cells, an initial step in the 
inflammatory cascade 
Guided by cytokines, the initial step of the leukocyte adhesion to endothelial cells is a binding to the 
endothelial cell layer via selectins (capture). This reversible process occurs several times (rolling) 
until the leukocytes adhere, mediated by integrins, in a firm way (tight junction). Finally, leukocytes 
pass through permeable junctions between endothelial cells (diapedesis) into the local site of 
inflammation.  
 
Whereas an acute inflammation provides a helpful protection against harmful stimuli, it 
can also turn into a chronic inflammation, if not terminated once the triggering insult is 
eliminated [17]. Chronic inflammation is related to numerous diseases such as diabetes 
mellitus type II, atherosclerosis, neurodegenerative diseases, cancer and cancer 
metastases [17, 28, 31, 32]. Reasons for chronic inflammations may comprise persistent 
injuries, extended exposure to toxic agents or autoimmune diseases. A prolonged 
inflammation is characterised by an orchestrated progressive shift in the type of cells 
present at the site of inﬂammation (neutrophil to monocyte recruitment) and by 
simultaneous clearance of dead cells along with a tissue repair that results in fibrosis and 
new vessel formation (angiogenesis) [33, 34].  
 
Rolling Tight junction Diapedesis Migration
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1.3 Molecular mechanisms of low-dose radiation therapy 
Although considerable progress has been achieved in the understanding of immune 
modulatory effects of ionising radiation, the underlying mechanisms are not fully resolved 
at present. During the last decades, however, multiple efforts have been made to unravel 
the molecular events following radiation exposure and subsequent irradiation-triggered 
pathways, especially following low doses. In line with that, previous studies revealed a 
kaleidoscopic variation of pathways involved in the anti-inflammatory effects of doses 
< 1 Gy, exhibiting a non-linear dose-response relationship most pronounced after a 0.5 Gy 
exposure [35, 36].  
As stated before, an initial event in the inflammatory cascades is the recruitment of PBMC 
and PMN to the site of local damaged tissue mediated by endothelial cells (EC). 
Consequently, experiments were performed on the role of EC in the anti-inflammatory 
efficacy of LD-RT. Among the first mechanisms reported to contribute to the immune 
modulatory effects was a significant reduction of leukocyte adhesion to inflammatory 
(TNF-α) stimulated ECs. The most pronounced effect was observed following a 0.5 Gy 
exposure [37-39]. This characteristic functionally coincides with a non-linear dose and 
time kinetics for the expression of the anti-inflammatory cytokine TGF-1 from EC both in 
vitro and in a murine model. Likewise, neutralization of TGF-1 restored leukocyte/EC 
adhesion indicating a key role of the protein in these effects [38, 40]. On the molecular 
level, a biphasic characteristic of DNA-binding and transcriptional activity of the 
transcription factors nuclear factor-B/p65 (NF-B) and activator protein 1 (AP-1) with 
local maxima at 0.5 Gy and 0.3 Gy (AP-1) at 8 hours and 24-30 hours after irradiation 
(NF-B) have been reported [41, 42].  
Apoptosis, a physiological cellular suicide program, induced by a variety of endogenous 
and exogenous stimuli including ionising irradiation [43], significantly impacts on immune 
regulation and radiation response. In line with that, irradiation of PBMC and PMN revealed 
a discontinuous increase of apoptosis with a plateau or peak following a 0.3 Gy to 0.7 Gy 
exposure [44, 45]. This may further contribute to a hampered recruitment of inflammatory 
cells by reducing cell numbers that is further supported by a decreased surface 
expression of the adhesion molecule E-selectin on ECs [38, 39] or an enhanced 
proteolytic cleavage of L-selectin from apoptotic PBMC [37]. In addition, a modulation of 
the pro-survival enzymes mitogen-activated protein (MAP) kinases, protein kinase B 
(AKT) and a reduced release of CCL20 from PMN following irradiation with doses below 
1 Gy have been reported to further contribute to the anti-inflammatory effects of LD-RT 
[46]. 
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Major cellular elements of the immune system further cover different subtypes of 
mononuclear leukocytes as main components of the innate host defence. According to 
this, a characteristic of the effector phase of inflammation comprises differentiation of 
monocytes into dendritic cells and inflammatory macrophages [47, 48]. The latter support 
inflammation by a plethora of functions such as phagocytosis followed by antigen 
presentation, secretion of cytokines and release of reactive oxygen intermediates/species 
(ROS) or nitric oxide (NO) [49, 50]. NO, mainly processed by the enzyme inducible nitric 
oxide synthase (iNOS) regulates vascular permeability, promotes oedema formation and 
is involved in the pathogenesis of inflammatory pain [51]. Following low-dose irradiation of 
activated macrophages, a decreased expression of the iNOS protein [52] as well as a 
hampered release of ROS and superoxide production [53] have been reported. More 
recent data further indicate a hampered nuclear translocation of NF-B/p65, a lowered 
secretion of the cytokine Interleukin 1 (IL-1) and an increased expression of TGF-1 from 
stimulated macrophages [54] concomitant with a significantly reduced migration capability 
[55]. In conclusion, low-dose X-ray irradiation, most pronounced at a dose of 0.5 Gy, 
induces an anti-inflammatory cytokine microenvironment for macrophages that might be 
accompanied by resolution of inflammation. 
A common characteristic of the effects as reported so far is a discontinuous dose-
response relationship shared with non (DNA)-targeted bystander, abscopal or adaptive 
effects [56]. These recent findings challenged the classical paradigm in radiation biology 
that deposition of energy to the nucleus and resulting DNA damage is responsible for the 
biological consequences of radiation exposure [57] and take into consideration a complex 
intercellular communication. Molecular mechanisms contributing or originating these non-
linear dose-response relationships, however, remain vague and most likely originate from 
an overlap of several processes that may be initiated at various threshold doses and 
display different time- and dose kinetics [36]. These effects became further evident by a 
biphasic regulation of inflammatory transcription factor NF-B [58] and a non-linear 
expression of X-chromosome linked Inhibitor of Apoptosis Protein (XIAP) in stimulated 
ECs [42]. In addition to its anti-apoptotic properties, the latter protein regulates the 
translocation and activity of NF-B and is therefore involved in the anti-adhesive 
properties of LD-RT (Figure 2). 
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Figure 2. Current model of immunomodulatory effects of low-dose radiation (< 1 Gy) 
on cells of the immune system 
Polymorphonuclear cells (PMN) respond to low-dose exposure with a locally increased rate of 
apoptosis, a hampered secretion of chemokine (C-C motif) ligand 20 (CCL20) chemokine and 
alterations in signal transduction pathways p38 mitogen activated protein kinase (MAPK) and 
protein kinase B (AKT). Furthermore, irradiation results in a hampered adhesion of peripheral blood 
mononuclear cells (PBMC) to the endothelium, mediated by the secretion of the anti-inflammatory 
cytokine transforming growth factor β1 (TGF-β1), a diminished expression of E-selectin on the 
surfaces of endothelial cells, a higher rate of apoptosis, and the proteolytic shedding of L-selectin 
from the surface. Moreover, in stimulated macrophages a reduced activity of the inducible nitric 
oxide synthase (iNOS) along with reduced levels of nitric oxide (NO), a lowered production of 
reactive oxygen species (ROS) and a diminished secretion of either interleukin-1β (IL-1β) and/or 
TNF-α may contribute to local anti-inflammatory effects. Figure modified according to [36]. 
 
In addition to an increasing knowledge of underlying cellular and molecular mechanisms, 
a multitude of animal models of arthritis have been established to study clinical 
inflammatory parameters and to confirm anti-inflammatory effects of low-dose irradiation. 
In 1933, von Pannewitz was the first to report on an improvement of symptoms, joint 
swelling and pain, following irradiation with single doses of 1 Gy in a model of mechanical 
destruction of cartilage and bone in rabbits [59]. In subsequent years, these 
characteristics were proven true in a variety of inducible inflammatory models in rabbit, 
rats and more recently in human tumour necrosis factor α (hTNF-α) transgenic mice [60]. 
These mice expressed the human cytokine TNF-α and developed a chronic polyarthritis at 
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an age of 4–6 weeks [61]. In summary, these models uniformly indicate that irradiation 
with low doses inhibits the proliferation of synovial cells and the synthesis of synovial fluid, 
reduces the destruction of cartilage and bone, hampers the expression of iNOS and IL-1β, 
increases expression of heat shock protein 70 (Hsp70) and heme oxygenase-1 (HO-1) 
[62] and secretion of the anti-inflammatory cytokine TGF-1, confirming a hampered 
leukocyte adhesion and extravasation. Beyond that, the best treatment effects were 
evident after daily fractions of 0.5 Gy and 1 Gy and an early onset of irradiation [63]. 
Notably, recent clinical investigations further support the preclinical observation that single 
doses of 0.5 Gy are isoeffective to a 1 Gy exposure, thus allowing total dose reduction 
and an improvement in patients` radiation protection [12, 63, 64]. 
 
1.4 DNA damage response in eukaryotic cells 
Eukaryotic cells have acquired complex molecular mechanisms to preserve chromosomal 
integrity in their genomes due to damages induced by ionising radiation, by-products of 
cellular metabolism (e.g. ROS) and environmental mutagens [65, 66] (Figure 3). 
Maintaining genomic stability is essential for prevention of chromosomal rearrangements 
that may otherwise result in malignant transformation and altered gene expression [67]. 
There is a wide range of different types of DNA damage that can arise within the cell, 
including base damages, single strand breaks, DNA-Protein- and DNA-DNA-crosslinks 
and most important DNA double-strand breaks (DSBs) [68]. Ionising radiation is able to 
give rise to all of these types of lesion and due to their substantially importance, DSBs are 
mainly repaired by two distinct repair mechanisms namely homologous recombination 
(HR) and non-homologous end joining (NHEJ) [66]. For damage repair by HR, an intact 
sister chromatid is required and therefore HR is restricted to the S and G2 phases of the 
cell cycle. By contrast, NHEJ rejoins the two broken DNA ends without the need of a sister 
chromatid. A fact that renders NHEJ functional in all phases of the cell cycle and thus the 
major DSB repair mechanism in mammalian cells [69].  
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Figure 3. DNA double-strand break signalling pathways and cellular radiation 
response 
DNA double-strand breaks (DSBs) caused by either exo- or endogenous inducers are recognised 
by sensors which send and intensify their signal via transducers to the effectors, resulting in cell 
cycle arrest, DNA repair and/or apoptosis. Figure modified according to [70]. 
 
1.4.1 Primary damage recognition and signal transduction 
The phosphatidylinositol 3-kinase-related (PIK3K) kinase ataxia telangiectasia mutated 
(ATM) is a protein kinase central to the damage recognition and signal transduction. It is 
recruited to DSB lesions via the meiotic recombination 11 homolog (MRE11)-RAD50-
Nijmegen Breakage Syndrome (NBS1) (MRN) complex [71]. Following activation by auto-
phosphorylation [72] and dimer dissociation, ATM phosphorylates a histone H2AX variant 
at serin139 thus, generating H2AX which in turn facilitates the recruitment of numerous 
key proteins of the repair machinery including among others p53-binding protein 1 
(53BP1), mediator of DNA damage checkpoint protein 1 (MDC1), breast cancer 1 early 
onset (BRCA1) [66] resulting in a H2AX signal up to 2 mega base pairs (Mbp) around the 
DSB [73]. 
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1.4.2 DSB repair mechanisms 
1.4.2.1 Non-homologous end joining 
Conditions like cell cycle phase, chromatin status (eu- or heterochromatin) and the 
complexity of the DSB determine the repair pathway preferred [66], with NHEJ to be the 
predominant pathway for the repair of radiation-induced DSBs [69]. This mechanism starts 
with the binding of Ku70 and Ku80 proteins to DNA ends in a manner that allows the 
Ku70/Ku80 heterodimer to translocate along the DNA and recruit the DNA-dependent 
protein kinase catalytic subunit (DNA-PKcs) complex [74]. DNA-PKcs in turn is responsible 
for the regulation of the DNA ends processing to generate the 3’-OH and 5’-P ends 
required for ligation [75]. The assembly of the Ku heterodimer and DNA-PKcs on DNA 
ends is followed by conformational changes, recruitment of Artemis for DSB end 
processing [76] and a complex termed DNA ligase IV/X-ray repair cross-complementing 
protein 4 (XRCC4) that facilitates the re-joining step [77]. 
 
1.4.2.2 Homologous recombination 
The initial step of the HR comprises an ATM-dependent phosphorylation of C-terminal-
binding protein 1 (CtBP)-interacting protein (CtiP) after binding of the MRN complex to the 
DSB. Activated CtiP resects the broken ends over a short distance which is continued by 
Bloom helicase (BLM) and exonuclease 1 (exo1) [78, 79]. The resulting single stranded 
DNA (ssDNA) is stabilised by the binding of replication protein A (RPA) [80]. Breast 
cancer type 2 susceptibility protein (BRCA2) exchanges RPA with RAD51 which results in 
the formation of a nucleoprotein filament [81]. This filament invades - guided by RAD54 - 
into the homologous sister chromatid resulting in ssDNA in the target chromatid 
(displacement loop (D-Loop)) [80]. The DNA synthesis starts at the 3'-end of the break by 
DNA-polymerase I, utilizing the sister chromatid as a template. During this process the 
single stranded area is enlarged (branch migration). Furthermore, the elongated 3'-end 
displaces from the homologous strand and binds to the resected second break end. HR is 
finished by filling up the single stranded areas and cutting of potential overlaps, resulting 
in two identical DNA double-strands [80, 82]. The final ligation is carried out by DNA-
ligase I. 
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1.5 Oxidative stress response 
Cells are permanently exposed to exogenous and endogenous noxae like irradiation, 
heat, nutrient deprivation and especially oxidative stress. The term ROS covers different 
kinds of chemically highly reactive molecules containing oxygen atoms, which play diverse 
roles in intracellular signal transduction, host defence, homeostasis and inflammation [83]. 
Important members of the ROS family are superoxide radical (O2-•), hydrogen peroxide 
(H2O2) and the hydroxyl radical (OH•) [84], which are mainly formed as natural 
endogenous by-products of the mitochondrial electron transport chain, since 
approximately 1-2% of its electrons are leaked as O2-• [85, 86].  
Following environmental stress, the level of ROS increases dramatically resulting in a 
significant damage to cellular structures and induction of DSBs [83, 87]. Since ionising 
radiation mainly exerts its cytotoxic activity by the generation of ROS, antioxidant systems 
to maintain and control cellular redox balances are highly relevant for the radiation 
response. Moreover, ROS are involved in immunological defence mechanisms e.g. in 
activated macrophages by mounting an oxidative burst against invading pathogens and 
have a physiological role in cellular signalling that extends to every cell type of the 
immune system [53, 88]. 
Other important players in the production of ROS comprise xanthine oxidase (XO) and 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOXs) [89, 90]. 
Activation of NOXs occurs in response to stimulation of insulin-, angiotensin-, fibroblast 
growth factor- and TNF-α receptors. Additional exogenous factors for ROS production are 
smoking (by activating NOX [91]) and auto-oxidizing xenobiotics [83]. The level of 
oxidative damage varies due to different conditions like hypoxia, obesity, hyper-glycaemia 
and high-cholesterol diet [84]. For instance, hypoxia was shown to result in a deregulation 
of the mitochondrial electron transport chain, followed by an increased production of ROS 
[92].  
ROS are capable of damaging a broad range of target structures including lipids, DNA 
and proteins, resulting in modifications and potentially severe consequences for the cell 
[83]. The interaction of ROS with varied lipids has a widespread impact by the formation of 
isoprostanes or oxidation of arachidonyl-palmitoyl-phosphatidylcholine to produce an 
agonist for Toll-like receptor 4 (TLR4), resulting in an inflammatory stimulus [93]. 
Moreover, ROS has been shown to induce a broad variation of DNA damage. Radicals 
can react with DNA by addition of double bonds present in DNA bases and by abstraction 
of an H atom from the methyl group of thymine and of the C-H bonds in 2-deoxyribose 
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[85]. This generates products such as 8-oxoguanine (8-OH-dG), 5-hydroxymethyluracil (5-
OH-Me-Ura) and 5-hydroxy-5-methylhydantoin (5-OH-MeHyd), which are linked to 
rheumatoid arthritis, diabetes mellitus type II and various types of cancer [94-97]. The 
most severe DNA damage, however, caused by ROS is the DSB [87, 98, 99]. Already one 
unrepaired DSB can be lethal or promote carcinogenesis [100, 101] 
Finally, ROS on the one hand are capable of inhibiting serine/threonine phosphatases and 
caspases by a reversible oxidation of their cysteine residues. On the other hand, oxidation 
of cysteines that coordinate Zn2+ in Zn2+-finger proteins (including kinases) may result in 
an activation of e.g. protein kinase C [83]. Additionally, metalloproteases which maintain 
an inactive state by coordinating Zn2+ can be activated by oxidation of cysteines. Growing 
evidence further exists on a role of ROS as a second messenger during cell growth, 
differentiation, inflammation [102, 103] and regulation of redox sensitive transcription 
factors like AP-1 and NF-B, which are linked to inflammation and have been shown to be 
modulated by LD-RT [104, 105]. 
A pivotal mechanism in the regulation of the cellular anti-oxidative stress/damage 
response and homeostasis is the activation of the transcription factor nuclear factor E2-
related factor 2 (Nrf2), which tightly controls the expression of genes encoding antioxidant 
proteins and ROS detoxifying enzymes [106]. Under non-stressed conditions, Nrf2 is 
coupled to Kelch-like ECH-associated protein 1 (Keap1) that fosters its proteasomal 
degradation [107]. In more detail, Keap1 is a substrate adaptor for the ubiquitination of 
Nrf2 in a cullin-3 (Cul3)-dependent manner, which leads to the continuous proteasomal 
degradation of Nrf2 [107]. Following oxidative stress, the ubiquitin E3 ligase activity of the 
Keap1–Cul3 complex declines by oxidation of cysteines in Keap1 while Nrf2 is stabilised 
and enters the nucleus [108]. After translocation, Nrf2 heterodimerises with small V-maf 
musculoaponeurotic fibrosarcoma oncogene homolog (Maf) proteins and binds to the 
antioxidant response element (ARE) which regulates the expression of multiple 
antioxidant and cytoprotective enzymes [106], most prominent superoxide dismutase 
(SOD), catalase (CAT) and glutathione-peroxidase (GPx) [109]. Consequently, Nrf2 is 
considered as a key player in the cellular stress response [110].  
 
 Introduction 17 
 
Figure 4. Major pathways of reactive oxygen species generation and 
detoxification 
Molecular oxygen (O2) can be processed into superoxide (O2•-) by specialised enzymes such as 
the nicotinamide adenine dinucleotide phosphate (NADPH)- or xanthine oxidases or originate as a 
by-product of cellular metabolism, particularly the mitochondrial electron transport chain. 
Superoxide dismutase (SOD) converts the O2•- to hydrogen peroxide (H2O2), which is further 
processed to water or alcohols via catalase (CAT) or glutathione peroxidase (GPx), respectively. 
Glutathione reductase renews the consumed glutathione by catalysing the reduction of glutathione 
disulphide (GSSG) to the sulfhydryl form glutathione (GSH). Figure modified according to [111].  
 
As an integral part of the ROS metabolism, SOD biochemically catalyses the dismutation 
of toxic O2•- into hydrogen peroxide H2O2 [112], which in turn is detoxified to H2O or 
alcohols in a glutathione-dependent reduction step by glutathione peroxidase (GPx) [113]. 
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Glutathione is renewed by glutathione reductase (GR) which catalyses the reduction of 
glutathione disulphide (GSSG) to the sulfhydryl form glutathione (GSH) [114]. Another 
possibility of detoxification is the decomposition of hydrogen peroxide to water and oxygen 
via CAT [112] (Figure 4).  
A misbalance of oxidants and antioxidants is linked to a plethora of human diseases like 
chronic obstructive pulmonary disease (COPD) [115], cancer [116] and ageing [117]. The 
disequilibrium can be caused by either excess levels of ROS or depletion in antioxidant 
defence pathways [118]. In several recent clinical studies, high levels of certain oxidative 
damage biomarkers seem to be a prognostic marker for a higher risk of disease [119-
121]. On the contrary, suggestions for an inverse correlation of particular biomarkers (e.g. 
neuroprostanes) and prognosis were reported by Seet et al. [122]. 
 
1.6 Aim of the project 
The purpose of the present thesis was to analyse molecular mechanisms implicated in the 
anti-inflammatory effects of low-dose radiation therapy. In line with that, a putative 
interrelationship between DNA damage repair and the involvement of ROS in a 
discontinuous dose-response relationship typically observed following low-dose irradiation 
was recently suggested. A mechanistic involvement of the DNA damage repair and 
cellular antioxidative response in the modulation of the anti-inflammatory effects and 
functional properties of ECs following low-dose anti-inflammatory irradiation, however, 
remains to be established. In the present study was aimed to analyse radiation effects in 
ECs with a particular focus on DNA damage repair, ROS production, expression and 
activity of the enzymes SOD, CAT, GPX and the redox-sensitive transcription factor Nrf2 
and to correlate expression of these factors to functional properties like leukocyte 
adhesion to ECs. 
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2 Material and methods 
2.1 Material 
2.1.1 Appliances 
Appliance  Model/Description Company 
Centrifuges mini Spin  
Eppendorf 5810 
UNIVERSAL 320R  
Eppendorf, Hamburg 
Eppendorf, Hamburg 
Hettich, Tuttlingen 
Developer Optimax Typ TR HS Laborgeräte,  
Wiesloch 
Electrophoresis chamber,   Bio-Rad, München 
ELISA reader VIKTORTM 1420 Multilabel 
Counter with Wallac 1420n 
Manager 
Perkin Elmer, Waltham 
USA 
Flow Cytometer FACSCalibur with Cell 
Quest Pro software 
Becton Dickinson, 
Heidelberg 
Freezing container Mr. Frosty™ Thermo Fisher Scientific, 
Dreieich 
IKA® shaker  MTS 4 IKA Labortechnik, Staufen 
Incubator HERA cell 240+240i Thermo Fisher Scientific, 
Dreieich 
Laminar flow hood HERA safe Thermo Fisher Scientific, 
Dreieich 
Linear accelerator SL75/5 Elekta, Crawley. UK 
Microscope (cell culture) AxioVert A1 Zeiss, Jena 
Microscope with software 
and camera system 
AxioImager Z1 with Axio 
Vision Imager Software 
4.6.2 and AxioCam MRm 
and AxioCam MRc 
Zeiss, Jena 
pH meter pH Meter 765 Calimatic Knick, Berlin 
Photometer Bio Photometer Eppendorf, Hamburg 
Real-time PCR  Step One Plus Applied Biosystems, 
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Darmstadt 
Semi-dry transfer cell Transblot SD Bio-Rad, München 
Shaker-incubator ES-20 BioSan, Riga, Latvia 
Water bath Typ W/B 5 Gesellschaft für Labor- 
technik, Burgwedel 
 
2.1.2 Consumables 
Description Company 
100 mm cell culture dishes Sarstedt, Nümbrecht 
15 ml tubes Greiner Bio-One, Frickenhausen 
50 ml tubes Greiner Bio-One, Frickenhausen 
60 mm cell culture dishes Sarstedt, Nümbrecht 
96 Well micro-plates Greiner Bio-One, Frickenhausen 
AmershamTM HyperfilmTM ECL High 
performance chemiluminescence film 
GE Healthcare, Buckinghamshire, UK 
Blotting paper GB003 VWR, Darmstadt 
CELLSTAR® 12-well cell culture plates Greiner Bio-One, Frickenhausen 
CELLSTAR® 24-well cell culture plates Greiner Bio-One, Frickenhausen 
CELLSTAR® 6-well cell culture plates Greiner Bio-One, Frickenhausen 
CELLSTAR® Filter Top cell culture flasks Greiner Bio-One, Frickenhausen 
Counting Chamber Slides, Fast read 102TM Immune-Systems, Paignton, UK 
Cover foil, Easy seal (80x140 mm) Greiner Bio-One, Frickenhausen 
Culture slides 8 Chambers BD Falcon, Erembodegem, Belgium 
FACS tubes, flow cytometry Sarstedt, Nümbrecht 
Fuji Medical X-Ray Film / Super RX Fujifilm, Düsseldorf 
Glass beakers Schott, Mainz 
Insulin syringes B.Braun, Melsungen 
Microscope Cover Glasses (18x18mm) and 
(24x60mm) 
Marienfeld, Lauda-Königshofen 
Microscopic Slides Thermo Fisher Scientific, Dreieich 
Pipette-tips with wide aperture Starlab, Hamburg 
Pipette-tips, TipOne®, Graduated, 
Blue/Yellow/White and Filter Tips 
Starlab, Hamburg 
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Polystyrene Round-Bottom tubes (14 ml) Beckton Dickinson, Heidelberg 
QIAshredder shredder column Qiagen, Hilden 
Reaction tubes (0.5 ml) Eppendorf, Hamburg 
Reaction tubes (1.5 ml, 2 ml) Sarstedt, Nümbrecht 
 
2.1.3 Chemicals and media 
Description Company 
2′ ,7′ -dichlorodihydrofluoresceindiacetate 
(H2DCFDA) 
MoBiTec, Göttingen 
4′.6-Diamidin-2-phenylindol (DAPI) Molecular Probes, Eugen 
Adefo Citroline 2000 (Developer) Adefo-Chemie, Dietzenbach 
Adefofix (Fixer) Adefo-Chemie, Dietzenbach 
Albumin Fraction V (pH 7) AppliChem, Darmstadt 
Ammonium peroxodisulfate (APS) Roth, Karlsruhe 
Biocoll Biochrome, Berlin 
Bovine Serum Albumin (BSA) AppliChem, Darmstadt 
Bromophenol blue AppliChem, Darmstadt 
Cy3-Streptavidin Jackson ImmunoResearch, West Grove, 
USA 
Deoxynucleotides (dNTP) Mix New England Biolabs, Frankfurt 
Dichloroacetic acid (DCA) AppliChem, Darmstadt 
Dithiothreitol (DTT) Sigma Aldrich, München 
dNTPs Thermo Scientific, Hudson, USA 
Dulbecco´s Phosphate Buffered Saline 
(PBS) 
PAA Laboratories, Pasching, Austria 
Dulbecco's Modified Eagle Medium 
(DMEM) 
Invitrogen, Darmstadt 
Ethylenediaminetetraacetic acid (EDTA) AppliChem, Darmstadt 
FACSFlow Becton Dickinson, Heidelberg 
Foetal Calf Serum Gold (A15-151) PAA Laboratories, Pasching, Austria 
HaltTM Protease Inhibitor Single-Use 
Cocktail 
Thermo Fisher Scientific, Dreieich  
HANKS’ Balanced Salt Solution Sigma Aldrich, München 
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Human TNF-α, premium grade Miltenyi Macs, Auburn, USA 
Milk powder Roth, Karlsruhe 
M-MLV reverse transcriptase Promega, Heidelberg 
NHS-biotin Sigma-Aldrich, München 
Non Reducing Lane Marker, Sample Buffer Thermo Fisher Scientific, Dreieich 
Penicillin / Streptomycin (5 U ml-1) Invitrogen, Darmstadt 
Pierce® ECL, Western Blotting Substrate Thermo Scientific, Karlsruhe 
Ponceau S AppliChem, Darmstadt 
ProSieve® QuadColor™ Protein Marker Lonza, Köln 
qPCR Rox Mix Thermo Scientific, Karlsruhe 
Random hexamers Thermo Scientific, Karlsruhe 
Ribonuclease A  QIAGEN, Hilden 
RNAse/DNase-free water Invitrogen, Darmstadt 
Rotiphoresis gel 30 Roth, Karlsruhe 
SDS-Pellets Roth, Karlsruhe 
Sodium chloride (NaCl) Sigma Aldrich, München 
Sodium dodecylsulfate (SDS) Roth, Karlsruhe 
Sodium hydroxide (NaOH) Sigma Aldrich, München 
Tetramethylethylenediamin (TEMED) Roth, Karlsruhe 
Trichloroacetic acid (TCA) AppliChem, Darmstadt 
Tris hydroxymethyl aminomethane (Tris) Roth, Karlsruhe 
Triton X-100 AppliChem, Darmstadt 
Trypsin/Ethylene diamine tetraacetic acid 
(EDTA, 0.25%) 
Invitrogen, Darmstadt 
Tween® 20 AppliChem, Darmstadt 
Vectashield® Mounting Medium Vector, Burlingame, USA 
 
2.1.4 Buffers and solutions 
2.1.4.1 Immunofluorescence 
 DAPI concentration   600 ng/ml in PBS 
 Fixing solution   3.7% Formaldehyde in PBS 
 Permeabilisation solution  0.25% Triton X-100 in PBS 
 Blocking/Antibody dilution solution  3% BSA in PBS 
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2.1.4.2 Western immunoblotting 
RIPA-Buffer (10x)  
 150 mM  NaCl 
 50 mM Tris, pH 8.0 
 1%  Triton X-100 
 0.5%  Dichloroacetic acid (DCA) 
 0.1%  SDS 
 
 1M Tris HCl (pH 8.8)  
  Adjust  volume to 500 ml with distilled water  
  Adjust pH 8.8 with HCl  
 
 1M Tris HCl (pH 6.8)  
  Adjust  volume to 500 ml with distilled water  
  Adjust pH 6.8 with HCl  
 
Electrophoresis Buffer  
 25 mM Tris 
 191 mM Glycine 
 3.47 mM SDS 
  Adjust volume to 1 l with distilled water 
 
TBS (10x) (pH 7.5)  
 1.53 M NaCl 
 100 mM Tris 
  Adjust volume to 1 l with distilled water 
  Adjust pH 7.5 with HCl 
 
TBS-T 
 100 ml  TBS (10x) 
 1 ml  Tween 20 
  Adjust volume to 1 l with distilled water 
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Milk powder block solution  
 5%  Milk powder in TBS-T 
 
Ponceau-Solution   
 65.7 µM Ponceau S 
 37.5 ml  Trichloroacetic acid (TCA) 
  Adjust volume to 250 ml with distilled water 
 
Reducing Electrophoresis Buffer (6x) 
 50%  Glycerol 
 0.6 M DTT 
 10.3%  SDS 
 0.35 M  Tris pH 6.8 
 0.012%  Bromophenol blue 
  Adjust volume to 10 ml with distilled water 
 
Transfer Buffer  
 30 mM Tris 
 160 mM Glycine 
 20%  Methanol 
 0.05% SDS 
  Adjust volume to 1 l with distilled water 
Table 1. Pipetting scheme for discontinuous SDS-electrophoresis gels (8.3 
cm x 7.3 cm x 1 mm) 
 Separation gel 10% Collection gel 5% 
Distilled water 4.7 ml 5.5 ml 
Rotiphoresis Gel 30 5.4 ml 836 µl 
Tris HCl (pH 8.8) 6.0 ml - 
Tris HCl (pH 6.8) - 626 µl 
10% SDS 162 µl 50 µl 
20% APS 54 µl 40 µl 
TEMED 12 µl 5 µl 
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2.1.5 Antibodies 
2.1.5.1 Primary antibodies 
Table 2. Primary antibodies used for immunofluorescence, flow cytometry 
and western immunoblotting 
Target Molecular 
Weight [kDa] 
Dilution Host Company Catalogue 
Number  
CAT 60 1:500 Rabbit Cell Signaling #12980 
CENP-F 330 1:500 Rabbit Santa Cruz sc-22791 
GPx1 22 1:1000 Rabbit Cell Signaling #3206 
Nrf2 97 1:250 Rabbit Cell Signaling #12721 
SOD1 
(Cu/Zn) 
18 1:1000 Mouse Cell Signaling #4266 
β-Actin 42 1:10000 Mouse Sigma Aldrich A5441 
H2AX 17 1:1000 Mouse Millipore JBW301 05-636 
 
2.1.5.2 Secondary antibodies 
2.1.5.2.1 Immunofluorescence/flow cytometry 
Table 3. Secondary antibodies used for immunofluorescence and flow 
cytometry 
Target Dilution Host Company Label Catalogue Number  
Anti-rabbit 1:500 goat 
Life 
technologies 
Alexa FluorR 
488 
A11034 
Anti-mouse 1:500 goat 
Life 
technologies 
Alexa FluorR 
594 
A11032 
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2.1.5.2.2 Western immunoblotting 
Table 4. Secondary antibodies used for western immunoblotting 
Coupled enzyme Specificity Host Dilution Company Catalogue 
Number 
Horse radish 
peroxidase 
mouse goat 1:1000 Santa Cruz #sc-2055 
Horse radish 
peroxidase 
rabbit goat 1:2000 Santa Cruz #sc-2054 
 
2.1.6 Primers and probes for real-time PCR 
Table 5. Forward/reverse primers and probes used for real-time PCR 
Target Sequence 5’ – 3‘ Primer Company Referen
ce 
Additional 
information 
SOD1 GGTCCTCACTTT
AATCCTCTATCCA
G 
SOD1 
forward 
MWG [123]  
SOD1 CCAACATGCCTC
TCTTCATCC 
SOD1 
reverse 
MWG [123]  
SOD1 AACACGGTGGGC
CAA 
SOD1 
probe 
MWG [123] 5‘Fluorescein 
(FAM) 
3‘ TAMRA 
RPL37A TGTGGTTCCTGC
ATGAAGACA 
RPL37A 
forward 
STRATIFYER [124]  
RPL37A GTGACAGCGGAA
GTGGTATTGTAC 
RPL37A 
reverse 
STRATIFYER  [124]  
RPL37A TGGCTGGCGGTG
CCTGGA 
RPL37A 
probe 
STRATIFYER  [124] 5‘Fluorescein 
(FAM); 
3‘ TAMRA 
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Table 6. Inhibitors and Activators 
Name Target Concentration Company Catalogue 
Number  
KU0060648 DNA-PK 1 µM Tocris 4840 
KU60019 ATM 1 µM Tocris 4176 
N-Acetyl- 
L-cysteine 
(NAC) 
Reactive 
Oxygen 
Species (ROS) 
10 mM Sigma Aldrich A7250 
AI-1 Keap1 100 µM Calbiochem 492041 
 
2.1.7 Commercial Kits 
Table 7. Kits used for activity analysis 
Target Application Company Catalogue 
Number  
Catalase  Enzymatic activity Abcam ab83464 
Glutathione 
peroxidase 
Enzymatic activity Abcam ab102530 
Superoxide 
dismutase 
Enzymatic activity Sigma Aldrich 19160 
Nrf2 DNA-binding 
activity 
Cayman Chemicals Cay600590-
96 
 
Table 8. Protein determination, RNA isolation and subcellular fractionation 
kits 
Name Company Catalogue Number  
Micro BCATM Protein Assay 
Kit 
Thermo Scientific 23235 
NucleoSpin® RNA Macherey-Nagel 740955 
Nuclear Extraction Kit Cayman Chemicals Cay10009277-1  
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2.1.8 Cells 
2.1.8.1 EA.hy926 and PBMC 
The human endothelial cell (EC) line EA.hy926 was established by a fusion of human 
umbilical vein endothelial cells (HUVEC) and the adenocarcinoma epithelial cell line A549 
[125] and was obtained from the American Type Culture Collection (ATCC). Peripheral 
blood mononuclear cells (PBMC) consisting of lymphocytes (T cells, B cells, and natural 
killer (NK) cells), monocytes and dendritic cells were enriched from EDTA blood of healthy 
donors by density gradient centrifugation (see 2.2.14) and were used in adhesion assays. 
 
2.2 Methods 
2.2.1 Cell culture and stimulation 
EA.hy926 ECs were grown in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% foetal calf serum (FCS) 50 U/ml penicillin and 50 μg/ml 
streptomycin at 37°C in a humidified atmosphere containing 5% CO2. Cells were 
passaged two times a week 1:10 by removing the media, washing with 5 ml PBS and 
adding of 3 ml trypsin-solution. After incubation at 37°C for 5 min, 7 ml DMEM was added 
and 9 ml of fresh DMEM was mixed with 1 ml of cell suspension and plated into T75 
flasks. 
For inflammatory stimulation, cells were commonly treated at 4 h before irradiation with 
the cytokine TNF-α at a concentration of 20 ng/ml. For adhesion assays, TNF-α was 
added 4 h before addition of PBMC according to previous published protocols [126]. 
 
2.2.2 Freezing and thawing of cells 
For stepwise freezing, EA.hy926 ECs were trypsinised, centrifuged (150 x g, 4 min), 
resuspended at a concentration of 3 x 106 cells/ml in precooled cryomedium (DMEM + 
20% FCS + 5% dimethyl sulfoxide (DMSO)), transferred into cryotubes and stored in a 
freezing container at -20°C to allow a gentle cooling by 1°C per hour. Next, tubes were 
transferred to a -80°C refrigerator for long term storage. Cells were thawed by transferring 
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into PBS followed by centrifugation (150 x g, 4 min) and resuspended in fresh and warm 
(37°C) medium and transferred into a T75 flask. 
 
2.2.3 Cell lysis 
For cell lysis, EA.hy926 ECs were washed once with PBS and scraped in 
radioimmunoprecipitation assay buffer (RIPA) at 24 h after irradiation. Lysates were 
transferred to a 1.5 ml reaction tube and incubated for 30 min on ice. After centrifugation 
at 14,000 x g for 15 min at 4°C, supernatant was transferred into a new 1.5 ml reaction 
tube and stored at -80°C.  
 
2.2.4 Determination of protein concentration 
The protein concentrations of lysates and nuclear extracts were determined by a 
bicinchoninic acid assay (BCA) kit. The assay is based on the reduction of Cu2+ to Cu1+ 
by proteins in an alkaline medium with the sensitive and selective colorimetric detection of 
the cuprous cation (Cu1+) by BCA. First, copper chelates with proteins in an alkaline 
environment form a light blue complex. In a second step, BCA reacts with the reduced 
(cuprous) cations to form a purple-coloured reaction product The BCA/copper complex is 
water-soluble and can be detected at 562 nm with an ELISA reader. The intensity of the 
coloured reaction product is a direct function of protein concentration that can be 
determined by comparing its absorbance value to a BSA standard curve, in parallel 
performed in the range of 0 – 40 µg/ml protein. 
 
2.2.5 SDS-PAGE/western immunoblotting 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-Page) gels were 
prepared for electrophoresis according to the pipette schema provided in Table 1 and  
20 - 30 µg (determined as described in 2.2.4) of total protein extract was loaded per lane. 
Prior to electrophoresis, samples were heated at 95°C for 10 min, centrifuged for 1 min at 
14,000 x g at 4°C, transferred to the electrophoresis apparatus and separated by 25 mA 
per gel. Next, gels were placed on 7 x 9 cm filter papers, soaked in transferring-buffer and 
covered with the blotting membrane followed by two additional filter papers and 
transferred on a semi-dry blotting apparatus for protein transfer at 50 mA per gel for 150 – 
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210 min. To confirm correct protein transfer and equal loading, the membranes were next 
incubated in Ponceau S solution for 1 min and subsequently destained with distilled water. 
Next, membranes were blocked in 5% milk powder/TBS-T at room temperature for 30 min 
until primary antibodies, diluted in 5% BSA/TBS-T prior to application, were added and 
incubated at 4°C overnight. For detection of proteins, membranes were covered with 
horseradish peroxidase-conjugated goat anti-rabbit and goat anti-mouse secondary 
antibodies (diluted in 5% milk powder/TBS-T) for 60 min. Finally, membranes were 
incubated for 1 min with working solutions of an enhanced chemiluminescent (ECL) 
substrate placed in plastic sheet protectors and exposed to Hyperfilm ECL prior to film 
development. 
 
2.2.6 SOD activity assay 
To assess SOD activity, 1 × 106 of EA.hy926 ECs were plated in T25 cell culture flasks 24 
h before irradiation. At indicated time points, medium was removed and cells were 
incubated with 200 μl of working solution buffer and 20 μl of enzyme working solution for 
20 min. The assay utilises a water-soluble tetrazolium salt which is converted to a water-
soluble formazan dye after reduction by a superoxide anion. The rate of the reduction 
through O2 is linearly related to the activity of xanthine oxidase (XO) and is inhibited by 
SOD. The reduction can be visualised by absorption at 440 nm and is used as an indirect 
quantification of SOD activity.  
Given that the focus was set on the irradiation effects on non-stimulated and TNF-α 
stimulated cells, SOD activity levels were given as relative values in arbitrary units relative 
to the activity of non-irradiated controls (set to 100%). 
 
2.2.7 Catalase activity assay 
For analysing CAT activity, 1 × 106 of EA.hy926 ECs were plated in T25 cell culture flasks 
24 h before irradiation. At indicated time points, cells were washed with PBS and 150 µl of 
ice cold assay buffer were added to the cells. For homogenisation, cells were pushed ten 
times through a 30 gauge syringe. After centrifugation with 10,000 x g for 15 min at 4°C, 
80 µl of the supernatant were transferred to a 96-well plate. 50 µl of developer mix was 
added and incubated for 10 min at room temperature. The assay is based on the reaction 
of unconverted H2O2 with OxiRed™ probe to produce a product which can be measured 
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spectrophotometrically. Absorbance was determined at a wavelength of 570 nm using an 
ELISA reader. Relative activity levels were calculated as described in 2.2.6. 
 
2.2.8 Glutathione peroxidase activity assay 
To assess GPx activity, 1 × 106 of EA.hy926 ECs were plated into T25 cell culture flasks 
24 h before irradiation. At indicated time points after X-ray exposure, cells were washed 
with PBS, suspended in 150 µl of ice cold assay buffer and homogenised by pushing ten 
times through a 30 gauge syringe. After centrifugation with 10,000 x g for 15 min at 4°C, 
50 µl of the supernatant were transferred to a 96-well plate. 50 µl of reaction mix was 
added and incubated for 10 min at room temperature. In the assay, GPx reduces cumene 
hydroperoxide while glutathione (GSH) is oxidised to glutathione disulphide (GSSG). The 
GSSG is reduced to GSH along with a consumption of nicotinamide adenine dinucleotide 
phosphate (NADPH) as the decrease of NADPH is proportional to GPx activity. Changes 
in NAPDH content were determined spectrophotometrically with an absorbance at a 
wavelength of 340 nm using an ELISA reader. Relative activity levels were calculated as 
described in 2.2.6. 
 
2.2.9 Subcellular fractionation 
For separation of cytoplasmic and nuclear fractions, EA.hy926 ECs were washed with 
PBS and scraped with 1 ml of ice-cold PBS. The scraped cells were transferred to pre-
chilled 1.5 ml reaction tubes and centrifuged at 150 x g at 4°C for 5 min. Supernatants 
were discarded and the pellet was resuspended in 500 µl ice-cold hypotonic buffer with 
phosphatase/protease inhibitors and incubated on ice for 15 minutes. Next, 25 µl of 
nonidet P-40 was added and the tubes were centrifuged at 14,000 x g at 4°C for 45 sec. 
The cytoplasmic fraction was transferred to 1.5 ml reaction tubes. The pellet was 
resuspended in 100 µl nuclear extraction buffer containing DTT, protease/phosphatase 
inhibitors and was incubated at 4°C for 90 min with shaking. Following incubation, the 
reaction tubes were centrifuged at 14,000 x g for 15 min. The supernatant containing the 
nuclear fraction was collected into new 1.5 ml reaction tubes. Protein concentrations were 
determined by BCA assay as described in 2.2.4. 
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2.2.10 Nrf2 DNA-binding activity assay 
For the measurement of DNA-binding activity, equal amounts of proteins (30 µg) in 
nuclear extracts (see 2.2.9) were incubated over night at 4°C with a specific consensus 
double-stranded DNA sequence containing the Nrf2 response element, immobilised onto 
the wells of a 96-well plate. After incubation, wells were emptied and washed 5 times with 
200 µl 1x wash buffer. Primary antibody, detecting specifically bound activated Nrf2, was 
added and incubated for 1 h at RT. After subsequent washing 5 times with 1x wash buffer, 
secondary HRP-coupled antibodies was added and again incubated for 1 h at RT. 
Following subsequent washing, 100 µl of developing solution was added. The reaction 
was stopped by adding 100 µl of stop solution. Quantification of DNA-binding activity was 
performed by sensitive colorimetric readout at 450 nm with an ELISA reader. Relative 
DNA-binding activity levels were calculated as described in 2.2.6. 
 
2.2.11 mRNA isolation 
For isolation of mRNA, cells were washed with PBS, trypsinised and centrifuged 5 min at 
180 x g. Pellets were resuspended and lysed in 350 µl RA1-buffer supplemented with  
3.5 µl of β-mercaptoethanol. The lysate was transferred to shredder columns and 
centrifuged for 1 min at 15,000 x g and 4°C. The flow through was loaded on 
NucleoSpin®Filter and centrifuged at 11,000 x g for 1 min into a 2 ml collection tube. After 
adding of 350 µl 70% Ethanol, the mixture was transferred on a NucleSpin® RNA II 
column and centrifuged at 11,000 x g for 30 s. 350 µl membrane desalting buffer was 
added on the column, centrifuged at 11,000 x g for 1 min and rDNase was added, 
followed by 15 min incubation. The column was washed with 200 µl RA2 buffer and 600 µl 
RA3 buffer each followed by centrifugation at 11,000 x g for 30 s. Washing was performed 
in 250 µl RA3 buffer followed by centrifugation at 11,000 g for 2 min. Finally, the RNA was 
eluted with 100 µl RNase free H2O and centrifugation at 11,000 x g for 1 min. For each 
sample, total RNA content was assessed by absorbance at 260 nm and purity by 
A260nm/A280nm ratios. 
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2.2.12 cDNA synthesis  
By the usage of reverse transcriptase, random hexamers and dNTPs, RNA was reverse 
transcribed to cDNA. First, 700 ng RNA and 350 ng random hexamers were denatured in 
a PCR device for 15 min at 70°C. This step was followed by addition of a master mix 
containing reverse transcriptase (200 U) and dNTPs (500 µM). Synthesis was performed 
as follows: 10 min 25 °C; 30 min 37°C; 30 min 42 °C. 
 
2.2.13 Real-time PCR 
For quantitative real-time PCR (qPCR), 2.5 µl cDNA was mixed with 12.5 µl of qPCR Rox 
Mix and 10 µM each forward/reverse primers and probes for SOD1 or RPL37A. Each 
qPCR was conducted in at least duplicates with the following setup: 15 min 95°C followed 
by 40 cycles each 15 s at 95°C and 1 min at 60°C. Relative quantification was performed 
by using the comparative Ct (ΔΔCt) method. This involves comparing the Ct values of 
irradiated with mock-treated samples. The Ct values corresponded to the number of 
cycles at which the fluorescence emission monitored in the real-time PCR reaction 
reaches a certain threshold. Additionally, the Ct values were normalised to an 
endogenous housekeeping gene using 60S ribosomal protein L37 (RPL37A) as internal 
reference. Relative mRNA expression levels were calculated as described in 2.2.6. 
 
2.2.14 Isolation and biotinylation of PBMC 
For the preparation of peripheral blood mononuclear cells (PBMC), EDTA blood of healthy 
donors was used. After dilution with HANKS’ balanced salt solution (1:1), 35 ml of the 
suspenison was carefully layered onto 15 ml of a Biocoll solution in a 50 ml tube. 
Following centrifugation at 1000 x g for 20 min without breaks, the layer containing the 
PBMC was carefully removed and cells were transferred into a new 50 ml tube and 
washed with HANKS’ solution twice by centrifugation at 180 x g for 8 min (Figure 5). 
Finally, cells were resuspended in RPMI medium + 10% FCS. All steps were performed at 
room temperature. PBMCs were biotinylated with a biotin-N-hydroxysuccinimid ester 
(NHS-biotin). For this purpose, 10 µl of NHS-biotin (10 mg/ml in dimethylformamid (DMF)) 
per 1 ml of PBMC in RPMI supplemented with 10% FCS were incubated for 15 min on ice. 
After centrifugation with 150 x g for 8 min, cells were suspended with 500 µl  
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1 M ammonium chloride and PBS was added subsequently. Cells were washed with 4°C 
PBS following a centrifugation with 150 x g for 8 min and resuspended in RPMI + 10% 
FCS and quantified using counting chamber slides.  
 
2.2.15 Adhesion Assay 
For adhesion assays (Figure 5), EA.hy926 ECs were plated into 12-well plates, grown to 
confluence and irradiated with doses ranging from 0 to 3 Gy in the presence of either 
DMSO or AI-1 (100 µM) or ROS scavenger NAC (10 mM). At 20 h after irradiation, cells 
were stimulated with TNF-α (20 ng/ml).  
 
 
Figure 5. Scheme of adhesion assay 
Upper row: PBMCs were isolated from EDTA blood of healthy donors, washed and subsequently 
biotinylated. Lower row: EA.hy926 ECs were grown to confluence, irradiated and stimulated. 
Biotinylated PBMCs were added, adhered for 30 min at 4 °C with dynamic shaking conditions and 
unbound PBMCs were removed by washing with PBS. After fixation, adhered PBMCs were 
visualised by Streptavidin-Cy3 conjugates and adhesion events (number of bound PBMC) were 
quantitated.  
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At 24 h after irradiation, biotinylated PBMCs at a concentration of 4 x 105 cells/ml were 
added to the EC and incubated for another 30 min at 4°C with gentle shaking (dynamic 
conditions). Next, unbound PBMCs were removed by washing with PBS and adherent 
PBMC were fixed with precooled (-20°C) Methanol and subsequently labelled with a 
streptavidin-Cy3 conjugate. Finally, adhesion events were quantitated by a fluorescence 
microscopy at a 250-fold magnification. The counts of a minimum of ten selected fields 
were averaged as one data point. The value of mock-irradiated samples was taken as a 
fixed intercept (100%) for the respective series of experiments. 
 
2.2.16 Immunofluorescence staining 
EA.hy926 ECs were grown on glass coverslips in 6-well plates for 48 h, treated with  
TNF-α, NAC, HR and NHEJ inhibitors or were mock-treated and irradiated. Inhibitors 
(Table 6) were added 1 h and NAC 4 h before irradiation. At different time points (1 h, 4 h 
and 24 h) after irradiation, cells were fixed with 3.7% formaldehyde for 15 min prior to 
washing twice with PBS. After permeabilisation (5 min 0.25% Triton-X 100 in PBS) and 
two times washing with PBS, cells were blocked in 3% BSA in PBS for at least 60 min. 
Primary antibodies (see 2.1.5.1) were incubated for 1 h followed by three washing steps 
with PBS and incubation with appropriate secondary antibodies (see 2.1.5.2.1) for 1 h in 
the dark. As the signal of phospho-histone H2AX may differ in a cell-cycle dependent 
manner with a doubled amount of DNA in the G2 phase leading to a higher number of 
H2AX foci [127], cells were stained for Centromere protein-F (CENP-F), which is only 
detectable in S/G2-phase cells. Subsequently, the coverslips were washed, nuclei were 
counterstained with DAPI solution and coverslips were mounted with Vectashield. Images 
were acquired using an AxioImager Z1 microscope, equipped with an Axiocam camera 
and Axiovision 4.6 software. For quantification, at least 40 nuclei in the G1 and 40 nuclei 
in the G2 phase were analysed and combined to one data point. CENP-F positive cells 
were excluded by their pan-nuclear H2AX-signal. 
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2.2.17 Flow cytometry 
2.2.17.1 Analysis of cellular protein level 
Intracellular protein levels were determined by flow cytometry using specific primary 
antibodies targeting antioxidative proteins. At indicated times, cells were trypsinised on ice 
and washed with PBS. Cells were fixed with 3.7% paraformaldehyde for 15  min, 
permeabilised by 96% ice cold ethanol for 30 min on ice and treated with blocking buffer 
(1% BSA in PBS) for 30  min. Primary antibodies at a dilution of 1:100 in blocking buffer 
were added for 60  min. Following washing with 0.5% BSA in PBS, appropriate secondary 
antibodies were added at a dilution of 1:100 in blocking buffer with incubation in the dark 
for 30 min at RT. Following final washes, cells were resuspended in PBS for FACS 
analysis using a cytometer and Cellquest Pro software. Relative expression levels were 
calculated as described in 2.2.6. 
 
2.2.17.2 Detection of reactive oxygen species  
Intracellular ROS levels were determined by flow cytometry using the cell membrane 
permeable dye 2′, 7′-dichlorodihydrofluoresceindiacetate (H2DCFDA), which is further 
processed in the cell by cleavage of the acetate groups by intracellular esterases and 
oxidation. Consequently the non-fluorescent H2DCFDA is converted to the fluorescent  
2', 7'-dichlorofluorescein (DCF) which can be measured by flow cytometry. 
Prior to harvesting, cells were incubated for 90 minutes with H2DCFDA at a concentration 
of 2 μM in serum-free medium. At indicated times, cells were trypsinised on ice, washed 
once with PBS and analyses were performed using a cytometer and Cellquest Pro 
software. The mean fluorescence of mock-treated cells was subtracted to eliminate 
unspecific background intensity for every sample. Relative ROS levels were calculated as 
described in 2.2.6. 
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2.2.18 Irradiation 
Irradiation was performed at a linear accelerator (SL75/5, Elekta) with 6 MeV/100 cm 
focus-surface distance and a dose rate of 4 Gy/min. In parallel, mock-treated controls 
were kept at ambient temperature in the accelerator control room. Dosimetry was 
regularly performed by medical physicists of the Department of Radiotherapy and 
Oncology. 
 
2.3 Data analysis 
Experimental data are presented as mean ± standard error of the mean (SEM) from at 
least three or more independent experiments. To test statistical significance, a two-sided 
unpaired Student’s t-test was performed using Excel® software. Results were considered 
statistically significant if a p-value of less than 0.05 was reached, more significant if 
p < 0.01 and highly significant if p < 0.001, respectively. Relative values were calculated 
as previously described in 2.2.6. 
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3 Results 
3.1 Time and dose kinetics of H2AX foci after low-dose radiation 
For decades, an anti-inflammatory and analgesic effect of LD-RT has been well 
established in the treatment of a multiplicity of benign diseases and chronic degenerative 
disorders [11]. Although the knowledge of the underlying cellular and molecular 
mechanisms is still at an early stage, a modulation of EC activity has already been proven 
to comprise a key element in the therapeutic effects of LD-RT.  
To analyse the effects of low-dose X-ray exposure on DNA damage induction and repair, 
immunofluorescence analysis of phosphorylation of the histone variant H2AX on serine 
139 (H2AX foci) as a marker for the presence of DNA-DSBs was applied [127]. 
For this purpose, EA.hy926 ECs were plated onto glass coverslips, grown to 95% 
confluence and were stimulated with TNF-α (20 ng/ml) or mock treated at 4 h before 
irradiation with single doses of 0.3, 0.5, 0.7 or 1 Gy. Histone H2AX foci levels were 
investigated at 1 h, 4 h and 24 h (residual foci) after irradiation. As H2AX foci levels may 
differ in a cell-cycle dependent manner with a doubled amount of DNA in the G2 phase 
[127], both, cells in the G1 and G2 phase as differentiated by the intensity of the 
centromere protein F (CENP-F) signal (Figure 6 A) were taken into consideration to 
improve accuracy of foci measurement.  
Irrespective of stimulation with TNF-α, at early time points (1 h, 4 h) a linear dose-
response relationship of H2AX foci was evident. Data from at least three independent 
experiments are depicted in Figure 6 B/C. By contrast, at 24 h after irradiation the number 
of residual H2AX foci was significantly (p < 0.05) elevated after a 0.5 Gy exposure as 
compared to irradiation with doses of 0.3 Gy and 0.7 Gy (Figure 6 D). Notably, these 
characteristics could be observed in both, G1 and G2 cells (with expected elevated 
numbers of H2AX foci in G2) indicating that the discontinuity in foci numbers at 24 h was 
not related to cell cycle distribution (Figure 6 E/F; Supplementary Figure 1). 
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Figure 6. Dose and time kinetics of H2AX foci in EA.hy926 EC following low-dose 
X-irradiation  
EA.hy926 EC were plated onto coverslips and stimulated with TNF-α (20 ng/ml) (black bars) at 4 h 
before irradiation with the doses indicated. Mock-treated cells (white bars) served as a control. At 
1 h (B), 4 h (C) and 24 h (D) post irradiation, cells were fixed, stained for H2AX, DAPI and  
CENP-F (A) and data of a total of 80 nuclei (40 G1 phase (CENP-F negative) and 40 G2 phase 
(CENP-F positive)) were combined for a single data point. Exemplary results for H2AX foci 24 h 
after irradiation of G1 phase cells (E) and G2 phase cells (F). Data represent means ± SEM from at 
least three independent experiments. Asterisks indicate signiﬁcant differences (* p < 0.05) vs. 
0.3 Gy and 0.7 Gy irradiated ECs. 
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In summary, these data indicate that the induction of DSBs and DNA damage repair in 
EA.hy926 ECs at early time points follows a linear dose-response relationship, at later 
time points, by contrast, a discontinuity with locally elevated levels of H2AX foci at 0.5 Gy 
were observed. The molecular mechanisms and factors involved in these 
characteristics, however, remain elusive and may originate from a dysregulation of DNA 
damage repair. Thus, next the impact of the most prominent DSB repair pathways HR and 
NHEJ on residual H2AX foci levels following low-dose irradiation was analysed. 
 
3.2 H2AX foci after low-dose radiation and inhibition of DNA damage 
repair 
For this purpose, small molecule inhibitors targeting ATM [128] and DNA-PK [129], 
proteins essential in HR and NHEJ were applied. ATM promotes the initial resection of 
DSBs by activation of the nuclease CtiP via phosphorylation [130]. This resection is 
required for processing of the DSB by other nucleases and is an important initial step in 
HR. Consequently, the number of DSBs repaired by HR is expected to be decreased after 
ATM inhibition by KU60019 (ATMi) [131]. DNA-PK and its catalytic subunit DNA-PKcs are 
responsible for the opening of the DNA ends to additional proteins involved in NHEJ. 
Furthermore, the enzyme is essential for processing of the DSB to generate the 3’-OH 
and 5’-P ends required for ligation [75, 132]. Since NHEJ is reported as the predominant 
repair pathway dealing with approximately 80% of X-ray-induced DSBs with rapid kinetics 
[101], an inhibition of DNA-PK by KU0060648 (DNA-PKi) is expected to result in a 
pronounced repair defect.  
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Figure 7. H2AX foci levels in EA.hy926 EC following low-dose X-irradiation in the 
presence of inhibitors for NHEJ and HR 
EA.hy926 EC were plated onto coverslips and stimulated with TNF-α (20 ng/ml) at 4 h before 
irradiation with the doses indicated. Cells were treated with inhibitors for (A) DNA-PK (DNA-PKi) or 
(B) ATM (ATMi) 1 h before irradiation. Mock-inhibitor treated cells served as a control. At 24 h post 
irradiation, cells were fixed, stained for H2AX, DAPI and CENP-F and data of a total of 80 nuclei 
(40 G1 phase (CENP-F negative) and 40 G2 phase (CENP-F positive)) were combined for a single 
data point. Data represent means ± SEM from at least three independent experiments. Asterisks 
indicate signiﬁcant differences (* p < 0.05) vs. 0.3 Gy and 0.7 Gy irradiated ECs.  
 
Both inhibition of ATM and DNA-PK did not affect background levels of H2AX foci in 
mock-irradiated and non-stimulated or TNF-α stimulated ECs, respectively. Irradiation with 
doses ranging from 0.3 to 1 Gy resulted in a linear dose-response-relationship of H2AX 
foci levels in line with an abolishment of the discontinuous dose-response characteristics 
as reported before. This effect was equal in ATMi and in DNA-PKi treated cells 
independent of TNF-α stimulation (Figure 7). 
Given that the number of H2AX foci 24 h after IR is only slightly but significantly 
increased after an exposure to 0.5 Gy, it may be possible that the effect of inhibition of the 
repair pathways on the biphasic induction of H2AX foci is not detectable due to an 
overlay with the elevated number of H2AX foci after inhibition of DNA damage 
repair. Consequently, these results do not clearly indicate an involvement of either HR or 
NHEJ in the biphasic appearance of residual H2AX foci following low-dose exposure. For 
this reason, other factors were analysed to further explore underlying molecular 
mechanisms implicated in the discontinuous appearance of H2AX foci following  
LD-RT. For this purpose, the next focus was set on ROS as a potential element since 
ROS are reported to induce DSBs [133]. 
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3.3 Levels of reactive oxygen species after low-dose radiation 
Following environmental stress, including ionising radiation, ROS levels increase 
dramatically resulting in a significant damage of cellular structures and induction of DNA 
damage [98]. Moreover, previous studies indicated a biphasic regulation of the oxidative 
burst in activated macrophages revealing changes in the production of ROS after 
exposure to LD-RT in another cellular system [53].  
To investigate a putative role of ROS production in the non-linear levels of H2AX foci, 
EA.hy926 EC were stimulated with TNF-α 4 h before irradiation or mock-treatment and 
ROS levels were analysed by measurement of the fluorescent dye  2',7'-dichloro-
fluorescein (DCF) using a flow cytometer. 
For controls, forward and side scatter analyses were performed, indicating that neither 
irradiation, stimulation with TNF-α nor application of DCF markedly alters cellular 
morphology (Figure 8 A). Furthermore the relative percentage (to total cells measured) of 
cells used for analysis was only marginally affected by LD-RT. The fluorescence of non-
DCF-stained cells, served as a blank value. As depicted in Figure 8 B, application of DCF 
increased the intensity of the fluorescence signal, which was further elevated by 
irradiation with a dose of 0.5 Gy indicating elevated levels of intracellular ROS. 
As displayed in Figure 8 C, a biphasic appearance of DCF fluorescence with a local 
maximum at a dose of 0.5 Gy became evident at 24 h after irradiation irrespective of 
inflammatory stimulation of the EC by TNF-α. At doses of 0.7 Gy a decreased expression 
of ROS was observed followed by an increase at a dose of 1 Gy.  
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Figure 8. ROS levels in EA.hy926 ECs following low-dose X-irradiation 
(A) Representative flow cytometer dot plots showing forward scatter (FSC) versus side scatter 
(SSC) for each treatment regimen. R-1 indicates the population of cells used for the analysis 
of 2′, 7′-dichlorodihydrofluoresceindiacetate (DCF) fluorescence. The numbers indicate the 
percentage of cells used for analysis - relative to total cells measured. (B) Representative 
histograms showing an increase of DCF fluorescence as a marker of ROS production in TNF-α 
stimulated, non-irradiated (blue line) and irradiated (0.5 Gy, red line) cells. Non-DCF treated cells 
(black line) served as a control and were subtracted for each quantification. (C) Quantification of 
relative DCF-fluorescence in EA.hy926 ECs at 24 h after irradiation with the doses 
indicated. Relative values were calculated relative to non-irradiated cells of the appropriate kind of 
stimulation. Data represent means ± SEM from at least three independent experiments. Asterisks 
indicate signiﬁcant differences (* p < 0.05) vs. 0.3 Gy and 0.7 Gy irradiated ECs. 
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apparently functional interrelationship between ROS production and H2AX induction 
following LD-RT was analysed. 
 
3.4 H2AX foci after low-dose radiation and scavenging of reactive 
oxygen species by N-acetyl-cysteine 
To further investigate a functional impact of ROS induction and a discontinuous level of 
H2AX foci at 24 h after LD-RT, EA.hy926 EC were irradiated in the presence of the ROS 
scavenger NAC. NAC is an aminothiol and synthetic precursor of intracellular cysteine 
and glutathione and comprises an antioxidant and ROS scavenger used in scientific 
research [134, 135]. In pilot experiments (Figure 9 A) NAC treatment (10 mM) was proven 
to significantly diminish total ROS levels to 20 % of non-treated controls in stimulated and 
non-stimulated EA.hy926 cells, irradiated with a dose of 0.5 Gy. 
As shown in Figure 9 B, the non-linear appearance of H2AX foci was completely 
abolished upon treatment with NAC, indicating a correlation between ROS production and 
the biphasic characteristics of H2AX foci levels. 
 
 
Figure 9. H2AX foci levels in EA.hy926 EC following low-dose X-irradiation in the 
presence of the ROS scavenger NAC 
EA.hy926 ECs were stimulated with TNF-α (20 ng/ml) or mock-treated and were irradiated in the 
presence of NAC (10 mM, applied 4 h before irradiation). At 24 h after irradiation relative DCF-
fluorescence (A) and H2AX foci levels (B) were analysed. Relative values were calculated as 
compared to mock-irradiated cells of the appropriate stimulation. Cells without NAC treatment 
served as a comparison (black bars). Data represent means ± SEM from at least three 
independent experiments. Asterisks indicate signiﬁcant differences (* p < 0.05; ** p < 0.01) vs. 0.3 
Gy and 0.7 Gy irradiated ECs or NAC vs. mock treated ECs. 
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As ROS production is mediated and regulated by a variety of enzymes implicated in the 
cellular anti-oxidant defence, next, experiments on the expression and activity of selected 
factors like SOD, CAT and GPx were conducted to explore molecular mechanisms 
implicated in the discontinuous induction of ROS and subsequent modulation of H2AX 
foci levels. 
 
3.4.1 Analysis of the antioxidative defence mechanisms after low-dose 
radiation 
3.4.1.1 Expression and activity of ROS detoxifying enzymes after low-dose 
radiation 
First, the impact of the enzyme SOD which is reported to be involved in detoxification of 
ROS by the conversion of the superoxide radical (O2•-) to H2O2 and O2 [136] was 
examined. SOD exists in three isoforms in mammals (cytoplasmic Cu/ZnSOD (SOD1), 
mitochondrial MnSOD (SOD2), extracellular Cu/ZnSOD (SOD3)), however, SOD1 is 
reported to be mainly responsible for total SOD activity [136]. Consequently, SOD1 
expression was investigated on the level of protein in western immunoblotting, while 
enzymatic activity was quantitated for total SOD by a colorimetric assay. 
 
As illustrated in Figure 10 A and Figure 10 C, total SOD1 protein expression and SOD 
activity displayed a discontinuous dose response dependency with a relative minimum at 
0.5 Gy as proven by western immunoblotting and colorimetric assays. By densitometric 
analysis, the relative amount of protein reduction was quantified (Figure 10 B). Exposure 
of EA.hy926 EC to 0.5 Gy and less pronounced to 0.7 Gy resulted in a reduction of 
approximately 50% and 30% of SOD1 expression in ECs, as compared to mock-irradiated 
controls (Figure 10 B). The expression of SOD1 at 24 h after a dose of 0.5 Gy was lower 
as compared to mock-irradiated controls, while the activity was equal to controls. 
However, the SOD activity in cells irradiated with a dose of 0.5 Gy was significantly 
decreased as compared to cells treated with a dose of 0.3 Gy and 0.7 Gy. 
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Figure 10. SOD1 protein expression and SOD activity in EA.hy926 ECs following low-dose X-
irradiation 
(A) Western immunoblots from total cellular proteins at 24 h after irradiation using antibodies 
against SOD1 and β-actin for loading control. Data are displayed as one representative from three 
independent experiments. (B) Reduction of SOD1 protein expression normalised to β-actin control 
as determined by densitometric analysis using the ImageJ software package and data from (A). (C) 
Relative SOD activity as analysed at 24 h after irradiation by using a colorimetric activity assay. 
Relative values were calculated to mock-irradiated cells with the appropriate stimulation. Data 
represent means ± SEM from at least three independent experiments. Asterisks indicate signiﬁcant 
differences (* p < 0.05) vs. 0.3 Gy and 0.7 Gy irradiated ECs. 
 
In summary, expression of SOD1 and its enzymatic activity is modulated by LD-RT, 
displaying a local minimum after a 0.5 Gy exposure in line with a maximum of ROS 
induction shown in Figure 8 C. Notably, changes in protein expression were more 
pronounced than the levels of activity. A putative explanation for this observation might 
be, that SOD1 is reported as the major component of SOD activity, but SOD2 and SOD3 
are also involved in the conversion of superoxide (O2•-) to H2O2 and O2. 
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H2O2 derived from SOD enzymatic activity is further processed by GPx or CAT, resulting 
in H2O, alcohols and O2 [112, 113]. To further unravel additional antioxidant factors 
implicated in the non-linear induction/regulation of ROS, an additionally focus was set on 
CAT and GPx expression and activity. Moreover, to further improve the sensitivity of 
protein detection as compared to western immunoblotting, levels of GPx1 protein, the 
most abundant of eight known GPx isoforms [137, 138] and expression of CAT were 
analysed in following experiments by flow cytometry (Figure 11 A). 
First, feasibility of the intracellular staining procedure and quantification of protein 
expression by a flow cytometer were evaluated (Figure 11 A). A clear increase of 
fluorescence intensity became evident when antibody treated samples were compared to 
mock-treated cells. Irradiation of the cells further resulted in a distinct enhancement of 
fluorescence levels, equivalent to increased amounts of the intracellular proteins. 
 
At 4 h before irradiation with doses ranging from 0.3 to 1 Gy, EA.hy926 ECs were 
stimulated with TNF-α (20 ng/ml) and relative CAT and GPx protein expression as 
determined by flow cytometry (20,000 cells/events) and colorimetric activity assays at 24 h 
after irradiation were analysed. 
Again, irrespective of stimulation with TNF-α, a non-linear dose-response relationship of 
both CAT (Figure 11 B) and GPx1 protein levels (Figure 11 C), with increased values at 
0.3 Gy, a minimum at 0.5 Gy and a further increase following exposure to doses of 0.7 
and 1 Gy was observed. In line with that observation, activity assays performed in parallel 
further confirmed a discontinuous appearance of enzymatic activity of CAT and GPx with 
decreased values (compared to doses of 0.3 or 0.7 Gy) following irradiation with a dose of 
0.5 Gy (Figure 11 D/E). 
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Figure 11. CAT/GPx1 protein expression and CAT/GPx activity in EA.hy926 cells 
following low-dose X-irradiation 
(A) Representative histograms showing FL1 fluorescence (protein expression) for control (dotted 
line; no antibody); non-irradiated cells (full line) and cells irradiated with 1 Gy (dashed line). Mock-
treated cells served as a control and their fluorescence values were subtracted in every 
quantification. Reduction of CAT (B) and GPx1 (C) protein expression as determined by a flow 
cytometer. Relative CAT (D) and GPx (E) activity analysed at 24 h after irradiation by using 
colorimetric activity assays. Relative values were calculated to mock-irradiated cells. Data 
represent means ± SEM from at least three independent experiments. Asterisks indicate signiﬁcant 
differences (* p < 0.05). 
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To sum up, these data indicate a discontinuous regulation of a variety of enzymes 
implicated in the cellular antioxidative defence with highly comparable dose kinetics and a 
common reduction most prominent following a 0.5 Gy exposure.  
 
3.4.1.2 mRNA expression of SOD1 after low-dose radiation 
Mammalian protein expression is regulated by a variety of mechanisms, like the level of 
transcription, post-transcriptional silencing, post-translational modifications and protein 
stability [139-141]. Notably, LD-RT is reported to modulate protein expression with  
(TGF-β1) [38] or without (iNOS) [142] influencing mRNA levels. Next, to investigate 
whether or not LD-RT affects mRNA levels of the proteins reported before, exemplary 
quantification of SOD1 mRNA was performed by qPCR. As this factor displayed the most 
notably regulation in protein expression after LD-RT, the levels of mRNA of SOD1 were 
evaluated 24 h after irradiation. 
Figure 12 depicts a non-linear level of SOD1 mRNA following irradiation with doses 
> 1 Gy, confirming a regulation of SOD1 on the mRNA level after LD-RT. Exposure of 
EA.hy926 EC to doses of 0.3 up to 1 Gy resulted in decreased SOD1 mRNA levels at a 
dose of 0.5 Gy as compared to 0.3 Gy and 0.7 Gy irradiated cells, similar to the levels 
obtained in mock-irradiated control cells.  
 
 
Figure 12. SOD1 mRNA expression levels in EA.hy926 cells following low-dose X-
irradiation 
Relative mRNA levels of SOD1 (ΔΔCT method) 24 h after low-dose radiation as analysed by qPCR 
with RPL37A as an internal control. Relative values were calculated relative to mock-irradiated 
controls. Data represent means ± SEM from at least three independent experiments. Asterisks 
indicate signiﬁcant differences (* p < 0.05) vs. 0.3 Gy and 0.7 Gy irradiated ECs. 
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These results indicate a modulation of antioxidative factors by low-dose irradiation on the 
level of transcription implicating further overall regulatory mechanisms to be involved. As a 
consequence, the putative role of the redox-sensitive transcription factor Nrf2 was 
analysed. 
 
3.4.2 Modulation of Nrf2 expression and DNA-binding activity  
To further elucidate common underlying molecular mechanisms, the expression and DNA-
binding activity of the transcription factor Nrf2 was evaluated by flow cytometry and 
colorimetric assays, respectively. Nrf2 is reported to be involved in the oxidative stress 
response by inducing the expression of detoxifying enzymes under the control of an ARE-
promoter [106, 109]. As a consequence, Nrf2 is considered as a key player in the cellular 
stress response [110] that might be involved in the regulation of enzymes by LD-RT 
reported in previous experiments.  
 
As presented in Figure 13 A, Nrf2 protein expression displayed a discontinuous dose-
response dependency with a slight decreased expression following irradiation with a dose 
of 0.3 Gy, a relative decrease at a 0.5 Gy exposure of approximately 90% (non-stimulated 
cells) and 80% (TNF-α stimulated cells) of non-irradiated cells, and a minor increased 
expression after doses of 0.7 Gy or 1 Gy, respectively. In agreement with these data, Nrf2 
DNA-binding activity was analysed in nuclear extracts by colorimetric ELISA utilizing a 
specific double-stranded DNA sequence containing the Nrf2 response element. Again, a 
discontinuous dose-response relationship was observed revealing a minimum value 
caused by an irradiation with a dose of 0.5 Gy (Figure 13 B). 
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Figure 13. Nrf2 protein expression and DNA-binding activity in EA.hy926 cells 
following low-dose X-irradiation 
(A) Relative changes in Nrf2 protein expression determined by flow cytometry at 24 h after 
irradiation. (B) Relative Nrf2 DNA-binding activity in nuclear extracts as analysed by a colorimetric 
assay, using a specific double-stranded DNA sequence containing the Nrf2 response element. 
Relative values were calculated as compared to mock-irradiated cells. Data represent means ± 
SEM from of at least three independent experiments. Asterisks indicate signiﬁcant differences (* p 
< 0.05) vs. 0.3 Gy and 0.7 Gy irradiated ECs. 
 
Interestingly, the reduction of Nrf2 expression following LD-RT exposure is more 
pronounced in TNF-α stimulated EAhy926 cells although the DNA-binding activity was 
extenuated more distinct in non TNF-α stimulated cells, proposing an effect of TNF-α on 
the level of Nrf2 DNA-binding activity. 
 
In summary, a discontinuous expression and enzymatic activity of the enzymes SOD, 
CAT and GPx concomitant with a lowered expression and DNA-binding activity of their 
common redox-sensitive transcription factor Nrf2 most pronounced 24 h following an 
irradiation with a dose of 0.5 Gy were reported. 
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3.5 Functional analysis 
3.5.1 Adhesion after scavenging of reactive oxygen species by N-acetyl-
cysteine and low-dose radiation 
Finally, to investigate whether low-dose X-irradiation modulated induction of ROS and 
Nrf2 activity is associated with altered functional properties of EA.hy926 ECs, leukocyte 
(PBMC) adhesion was analysed in the presence of the ROS scavenger NAC or the Nrf2 
activator AI-1. The adhesion process is a major initial step in the inflammatory cascade, 
guided by modulatory cytokines/chemokines and surface molecules like integrins and 
selectins [142] and is reported to comprise a key modulatory element in the anti-
inflammatory efficacy of LD-RT. 
 
Figure 14 A exemplarily indicates PBMCs adhered to ECs and visualised by a Cy3-
Streptavidin complex that binds to a biotin protein coupled to the membranes of the 
PBMCs. 
As illustrated in Figure 14 B and in accordance with previous published data [39, 143], 
PBMC/EA.hy926 EC adhesion was significantly suppressed by more than 50%, 24 h after 
irradiation with a single dose of 0.5 Gy. On the contrary, ROS scavenging by NAC 
resulted in a pronounced increase of adhesion events and thus implicates a partial, but 
significant diminution of the anti-adhesive effect of low-dose X-ray exposure.  
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Figure 14. Adhesion of PBMC to TNF-α stimulated EA.hy926 ECs following low-
dose X-irradiation in the presence or absence of NAC 
(A) Representative pictures of ECs (transmitted light) and adhered PBMC (Cy3; in red) to ECs. (B) 
The percentage of adherent PBMCs to endothelial cells after irradiation with the doses indicated in 
the presence (dashed line) or absence (full line) of NAC (10 mM) relative to the values of non-
irradiated stimulated controls (TNF-α (20 ng/ml) given 4 h before adding of PBMCs). PBMCs were 
incubated for 30 min at 4°C with gentle shaking, adherent cells were fixed, visualised and adhesion 
events were quantitated by fluorescence microscopy. Data represent means ± SEM from at least 
three independent experiments. Asterisks indicate signiﬁcant differences (* p < 0.05) as compared 
to non-treated cells. 
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3.5.2 Adhesion after indirect activation of Nrf2 and low-dose radiation 
According to preceding experiments, Nrf2 reveals a non-linear protein expression and 
DNA-binding activity that coincides with a discontinuous induction of ROS that in turn 
functionally mediates the adhesion process. Accordingly, in this work, it was analysed 
whether activation of the Nrf2 by a small molecule activator also results in a modification 
of the adhesion process.  
As a permanent degradation of Nrf2 is mediated by binding to Keap1, a small molecule 
inhibitor (AI-1) of this interaction was applied to stabilise the Nrf2 protein. AI-1 covalently 
modifies cysteine 151 residue (Cys151)-dependent binding of Keap1 to Nrf2, serving as 
an anchor for adaptor for Cul3-ubiquitin E3 ligase complex [144]. Consequently, binding of 
Keap1 to Nrf2 is disrupted, enabling Nrf2 nuclear translocation and an increased 
transcription of target genes. 
Control experiments ensuring the activity of the compound AI-1 in EA.hy926 EC revealed 
a significantly decreased ROS production, both in 0.5 Gy-irradiated cells and mock-
treated cells, respectively (representative results for 0.5 Gy are depicted in Figure 15 A). 
Moreover, a stabilization of the Nrf2 protein by AI-1 was clearly visible in western 
immunoblotting by increased protein expression upon Al-1 treatment (Figure 15 B). 
Incubation with the Nrf2 activator AI-1 resulted in a significantly less pronounced reduction 
of PBMC/EC adhesion especially following irradiation with doses of 0.5 and 0.7 Gy (Figure 
15 C), similar to the effects observed by ROS scavenging with NAC as reported before. 
This effect was less distinct at lower (0.3 Gy) and higher (1 Gy and 3 Gy) doses of 
irradiation. 
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Figure 15. Adhesion of PBMC to TNF-α stimulated EA.hy926 ECs following low-
dose X-irradiation in the presence of AI-1 or DMSO 
(A) Quantification of relative DCF-fluorescence in EA.hy926 ECs at 24 h after irradiation with a 
dose of 0.5 Gy in the presence of AI-1 or solvent DMSO. (B) Western immunoblots from total 
cellular proteins at 24 h after irradiation using antibodies against Nrf2 and β-actin for loading 
control. Data are displayed as one representative from three independent experiments. (C) The 
percentage of PBMCs adherent to ECs after irradiation with the doses indicated in the presence of 
DMSO (dashed line) or AI-1 (100 µM) (fine dashed line). Relative values were calculated in 
comparison to mock-irradiated, stimulated cells. Cells without treatment (full line) are shown as a 
reference. PBMCs were incubated for 30 min at 4°C with gentle shaking, adherent cells were fixed, 
visualised and adhesion events were quantitated by fluorescence microscopy. Data represent 
means ± SEM from at least three independent experiments. Asterisks indicate signiﬁcant 
differences (* p < 0.05) as compared to DMSO-treated cells. 
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0.5 Gy. These experiments thus clearly indicate that the reduction of PBMC adhesion to 
stimulated EAhy926 ECs is at least in part mediated by Nrf2 activation and ROS levels.  
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4 Discussion 
Based on growing evidences for non-(DNA) targeted effects, the classical paradigm in 
radiation biology, that deposition of energy to the nucleus and resulting DNA damage 
solely is responsible for the biological consequences of radiation exposure has been 
challenged. Among these novel evidences, bystander or out of field (abscopal) 
mechanisms and adaptive responses have received significant attention in the last 
decades [145, 146]. These novel concepts further take into consideration an intercellular 
communication [147] and a close interrelationship of irradiated cells with the surrounding 
tissue and components of the immune system. Furthermore, a hallmark of these effects is 
a common appearance at low doses and a non-linear dose-response relationship [56] 
shared with the anti-inflammatory effects of low-dose X-irradiation therapy (LD-RT) 
investigated in the present work. Exploring underlying cellular mechanisms, a variety of 
recent investigations further indicated the involvement of a multitude of cellular immune 
compounds and pathways in these characteristics, including a modulation of PBMC 
adhesion to ECs and a modulation of cytokine and transcription factor expression in ECs, 
leukocytes and macrophages (reviewed in [142, 148]). 
Although considerable progress has been achieved in the understanding of immune 
modulatory effects of ionising radiation, the underlying molecular mechanisms are 
presently not fully resolved and a deeper insight in the interplay and modulation of the 
various cellular processes by irradiation has yet to be achieved. In line with that, high-
dose exposure with single doses exceeding 2 Gy displays a pronounced pro-inflammatory 
effect [3], whereas irradiation with single doses below 1 Gy experimentally and clinically 
reveals anti-inflammatory properties [6, 142, 149]. The fact that different doses affect the 
immune system in diametrically opposed ways may implicate the involvement of complex 
mechanisms of DNA damage response and immune modulation differentially operating at 
different dose levels. However, the impact of DNA damage response, ROS production 
and the antioxidative defence system to give rise or contribute to these effects in EC 
remains unsolved. 
In that context, ECs may comprise ideal targets for modulatory properties of low-dose 
radiation exposure due to their crucial role in the regulation of the local inflammatory 
process. This is due to their ability to recruit leukocytes to the site of local inflammation 
and by expressing a variety of cytokines/chemokines essential for the inflammatory 
cascades [150]. In the present study the focus was set on the endothelial cell line 
EA.hy926 which has been established by fusion of primary human umbilical vein 
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endothelial cells (HUVEC) and the adenocarcinoma epithelial cell line A549 [125]. As it 
cannot be excluded that the cancerous fusion partner A549 may influence some 
properties of EA.hy926 cells, exemplary experiments on SOD expression and activity 
HUVECs were performed indicating a similar dose-response relationship [151]. 
Comparability between these cells is further supported by studies indicating similarities 
between EA.hy926 ECs and HUVECs in terms of adhesion properties and surface marker 
expression if stimulated with the cytokine TNF-α [152]. Additionally, experiments 
performed in primary human microvascular ECs (HMVEC) for GPx expression and activity 
indicating a similar dose response relationship as depicted in Figure 11 [153]. Thus, 
EA.hy926 cells may comprise a valuable system to investigate the role of DNA damage 
response, ROS induction and cellular antioxidative defence mechanisms following low-
dose irradiation. 
 
A putative interrelationship between DNA damage repair and a discontinuous dose-
response relationship following low-dose irradiation was recently suggested [154]. By 
assessing the number of serine 139 phosphorylated histone H2AX (H2AX) foci, a marker 
of radiation-induced DSBs [73], a biphasic behaviour of H2AX foci levels with a low-dose 
hypersensitivity in whole blood and less pronounced for isolated T-lymphocytes after X-
irradiation was reported in line with a delayed repair with 40% of initial H2AX foci, 
persisting 24 hours post-irradiation [154]. A mechanistic involvement of DNA damage 
repair mechanisms in the modulation of these non-linear dose-response effects remains 
to be established. However, one may assume that the discontinuous levels of residual 
H2AX foci in the present thesis are related to the phenomenon of low-dose hyper-
radiosensitivity (HRS) and induced radioresistance (IRR), which have been reported for 
cellular survival at doses below 0.3 Gy and in the dose range of 0.3 Gy to 0.6 Gy, 
respectively [155]. The current understanding of these processes is that the region of HRS 
(< 0.3 Gy) represents an area of increased apoptotic cell death in cells that failed to 
undergo an ATM-dependent G2 phase cell cycle arrest and thus proceed through mitosis 
with damaged DNA. On the contrary, a transition to IRR originates from a change in the 
balance of G2 checkpoint induction, allowing time for repair of DNA damage and increase 
cell survival. Moreover, Xue et al. demonstrated by inhibition or activation of ATM, that 
HRS/IRR is ATM-dependent, as there were no HRS/IRR observable in either ATM 
stimulator or inhibitor treated cells [156]. In this regard, accumulating evidences exist on a 
reduced NHEJ repair response associated with HRS and persistent RAD51 foci, an 
essential component of the ATM-dependent HR pathway at late time points after low-dose 
exposure [157]. This may indicate that a deregulation of both repair pathways may 
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contribute to the non-linear numbers of DSBs, although in the present investigation, 
ambiguous data were obtained after inhibition of ATM by KU60019. Moreover, future 
investigations should further address a putative involvement of accumulation of DSBs at 
stalled replication forks [158] to contribute to the levels of residual H2AX following a low-
dose exposure especially in S phase cells. 
 
Although as yet not proven in an experimental setup the “Local Effect Model” (LEM) 
suggested by Friedrich et al. [159] might serve as a theoretical hypothesis to unravel the 
question of the appearance of discontinuous dose-response relationships. This model is 
based on the assumption that DNA is organised in giant loops [160, 161], consisting of 
about two Mbp length [162, 163]. It further proposes that DSBs can occur in an isolated 
manner (1 DSB per giant loop) or in a clustered form (≥ 2 DSBs per giant loop) (Figure 16 
A). Although not experimentally accessible at present, one may speculate that the ratio of 
isolated to clustered DSBs is changing in a dose of range of 0 – 1 Gy with 0.5 Gy as a 
threshold dose, potentially leading to a shift in cellular reactions in response to an 
increased relative amount of clustered DSBs (Figure 16 B). Although this hypothesis still 
remains highly speculative, it might give a valuable explanation for the non-linear dose 
effects reported in this work as well as in numerous publications on the immune 
modulatory efficacy of low-dose irradiation (reviewed in [36]).  
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Figure 16. Scheme of isolated or clustered DSB (Local Effect Model) and proposed 
model for the origination of a non-linear dose-response 
(A) An induction of one DSB in a single DNA loop leads to an isolated DSB, whereas two or more 
DSBs in a single DNA loop result in clustered DSBs with potential loss of large DNA pieces. (B) 
Proposed relative amounts of isolated DSBs (full line) in comparison to clustered DSBs (dashed 
line) suggesting a cross-over of both populations at a threshold dose of 0.5 Gy. (Figure 16 (A) was 
modified according to [159].)  
 
Following environmental stress, levels of ROS increase dramatically resulting in a 
significant damage to cellular structures and induction of DSBs [98, 133]. Since ionising 
radiation exerts its cytotoxic activity in particular by the generation of ROS, antioxidant 
systems to maintain and control cellular redox balances are relevant for cellular survival 
and radiation response. Besides, ROS are essential for various biological functions, 
including cell survival, cell growth, proliferation, differentiation, and immune responses 
e.g. in activated macrophages by mounting an oxidative burst against invading pathogens. 
Additionally, ROS have a physiological role in cellular signalling that extends to every cell 
type of the immune system [53, 88, 164].  
 
Although recent data imply an involvement of a variety of molecular mechanisms in the 
anti-inflammatory characteristics of EC following low-dose irradiation [36], the impact of 
ROS production to give rise or contribute to these effects in EC remains elusive. Here for 
the first time a discontinuous induction of ROS in Ea.hy926 ECs following a low-dose  
X-ray exposure with a most pronounced effect at a dose of 0.5 Gy (Figure 8) is reported. 
Notably, a discontinuous regulation of ROS production following X-irradiation in a 
comparable dose range between 0.3 and 0.6 Gy is also reported in stimulated murine 
RAW 264.7 macrophages mounting an oxidative burst [53]. However, as compared to 
elevated levels at a dose of 0.5 Gy in the present investigation, a significant reduction of 
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ROS production was observed in these cells. This may indicate that the variety of 
regulatory effects observed after low-dose X-ray exposure may reflect different functional 
consequences that are specific for a given cell type (ECs vs. macrophages) or cellular 
(micro-) environment. Interestingly, Kang et al. recently demonstrated that ROS induction 
after treatment of osteosarcoma and mammary epithelial cells with the radiation mimetic 
neocarzinostatin is, at least in part, mediated by histone H2AX overexpression or DNA 
damage-triggered H2AX accumulation. Moreover, H2AX foci induction by ROS was 
abrogated by treatment with the ROS scavenger NAC, knockdown of the NADP(H) 
oxidase Nox1 and by a dominant negative Ras-related C3 botulinum toxin substrate 1 
(Rac1) mutant (Rac1N17) indicating an involvement of the Nox1 and Rac1 GTPase 
pathway [165]. These findings thus point to a more complex and reciprocal regulation of 
H2AX and ROS production that may further contribute to a discontinuous appearance of 
H2AX foci in EA.hy926 ECs after low-dose X-irradiation in the dose range < 1 Gy. 
 
Cellular ROS production is tightly regulated by coordinated activities of pro-oxidant and 
anti-oxidant defence systems. To further elucidate mechanisms that may contribute to 
non-linear levels of H2AX foci and ROS, the activity of the enzyme SOD that dismutates 
O2•- into H2O2 with the latter to be degraded into H2O and O2 by CAT and GPx activity 
was analysed [112]. In the present study, a diminished activity of these enzymes in 
EA.hy926 ECs most pronounced at 24 h after irradiation with a dose of 0.5 Gy was 
observed (Figure 10, Figure 11). 
Data on the expression of SOD following low-dose irradiation, however, are controversial 
in literature at present. Similar to the findings presented in this work, they include a 
reduction in SOD activity in spleens of healthy BALB/C mice following total body 
irradiation with a dose of 0.4 Gy [166]. By contrast, they further comprise reports on 
increased mRNA expression following irradiation with a dose of 0.2 Gy or 0.5 Gy in 
splenic tissue of BALB/c or C57BL/6NJcl mice suffering from hepatopathy or cold brain 
injury [167, 168]. These results pinpoint to a cell type- and environment-related regulation 
of anti-oxidative defence mechanisms that should be addressed in continuative 
investigations on the role of SOD in low-dose irradiation responses in different cellular 
systems. 
 
Based on the findings on SOD expression the analyses were expanded to CAT and GPx, 
additional factors in the antioxidative defence system to toxic H2O2 by reducing it to H2O in 
a glutathione-dependent reaction (GPx). Again, a discontinuous dose-response 
relationship of CAT and GPx expression and activity with a local minimum following 
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irradiation with a dose of 0.5 Gy (Figure 11) was observed. As for SOD activity, data on 
the expression of CAT and GPx in literature are ambiguous. In accordance to the results 
in the present thesis, Peltola et al. for instance, reported on a downregulation (18%) of 
CAT activity at 24 h after irradiation with a dose of 0.5 Gy and 26 % after irradiation with 
3 Gy in mouse liver tissue. This downregulation, however, was not detectable in the testis 
[169] indicating a tissue or cell type-specific regulation of CAT activity upon irradiation 
treatment. On the contrary, Beck and colleagues indicated an upregulation of factors 
implicated on oxidative stress response in EA.hy926 ECs following a 0.5, 2 and 5 Gy 
exposure [170]. Importantly, the latter data were derived from cells irradiated with high 
LET nickel ions indicating that the quality of radiation may substantially impact the 
expression of anti-oxidative factors in ECs.  
 
The major cellular system to defend against the deleterious consequences of ROS 
induction and to restore a cellular redox homeostasis involves a multitude of genes 
regulated on the level of transcription by the presence of an ARE element in their 
promoter regions [171]. This motive is activated primarily by binding of the transcription 
factor Nrf2 that commonly regulates the transcription of a variety of antioxidant factors and 
ROS detoxifying enzymes [171]. In the present investigation, for the first, a time a non-
linear expression and DNA-binding activity of Nrf2 (Figure 13) that was related to a 
diminished expression of SOD1, CAT and GPx1 (Figure 10, Figure 11) was observed. In 
accordance to these findings, a plausible involvement of Nrf2 in response to low-dose 
radiation exposure has already been demonstrated in a variety of cellular systems. For 
instance, an elevated expression and nuclear translocation of Nrf2 at 24 h following  
-irradiation with doses higher than 0.1 Gy has been observed in RAW264.7 macrophages 
[172]. More recent data further confirmed the induction of Nrf2 and enhanced expression 
of SOD and heme oxygenase (HO)-1 in human skin fibroblast HS27 cells following  
X-irradiation with a dose of 0.5 Gy [173]. By contrast, Nrf2 activation was not detectable at 
24 h after irradiation with doses of 1-2 Gy in human monocytic THP1 cells [174] or was 
delayed for 5 days following a 2-8 Gy exposure in human breast cancer cells [175]. This 
further suggests a differential and cell type-specific induction and regulation of 
antioxidative mechanisms after irradiation with an early onset in cells of the immune 
system, e.g. ECs and macrophages as compared to malignant cells. 
 
Notably, the reduction of Nrf2 DNA-binding activity at 0.5 Gy (Figure 13 B) is more 
pronounced as compared to the reduction in total Nrf2 protein expression (Figure 13 A), 
indicating additional levels of regulation. Indeed, Nrf2, in association with small V-maf 
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avian musculoaponeurotic fibrosarcoma oncogene homolog (Maf) transcription factor or 
members of the Jun protein family, forms an heterodimeric transcriptional complex to bind 
and regulate ARE-driven target genes [176, 177]. Thus, it is tempting to speculate that a 
modulation of those cofactors may further contribute to the decreased Nrf2 DNA-binding 
activity.  
 
When assaying functional consequences of ROS induction and Nrf2 expression in 
EA.hy926 ECs, here it is reported that both approaches (pre-treatment with the ROS 
scavenger NAC or the Nrf2 activator AI-1), are leading to an abolishment of the diminution 
of PBMC adhesion to ECs following a 0.5 Gy exposure [38, 39]. The adhesion assay used 
in this investigation is an established model for the modulation of the inflammatory 
response and it is also discussed as a marker for radiation exposure [178]. Hallmann et al. 
[179, 180] and Morigi et al. [181] demonstrated, that two different assay conditions of 
adhesion of PBMC onto activated ECs are influenced by different cell adhesion 
molecules. Whereas cell adhesion in the dynamic assay/shear stress at 4°C is 
predominantly mediated by selectin, integrins account for most of the cell adhesion in a 
static assay (37°C, with no agitation). The dynamic experimental conditions used in this 
work (shear stress, 4°C) were adapted to measure selectin-mediated adhesion as 
preceding investigations revealed a reduced expression of the surface marker E-selectin 
on activated EA.hy926 to contribute to the modulation of the adhesion process following 
LD-RT [39]. 
The attenuation of the hampered PBMC adhesion by treatment with the ROS scavenger 
NAC or by an indirect activation via stabilization of Nrf2 (Figure 14 B, Figure 15 C) further 
pinpoints to the importance of ROS as a modulator of inflammatory pathways following 
low-dose irradiation. In line with that, H2O2 has been reported to stimulate neutrophil and 
eosinophil granulocyte adhesion in an autocrine or paracrine manner by upregulation of 
β2 integrin [182]. Moreover, the authors speculate on ROS to comprise an effector for 
changes in morphological or functional properties of ECs, including permeability and the 
expression of adhesion molecules. Indeed, growing evidence has emerged that ROS are 
involved in cellular adhesion to surfaces [183] as well as in monocyte binding to ECs 
[184]. In line with that, the inhibitory properties of anti-inflammatory drugs like Tanshinone 
IIA or simvastatin on TNF-α induced monocyte EC adhesion has been linked to 
suppression of isoprenoid-dependent generation of ROS [185], transcription factor 
Nuclear factor B (NF-B)-dependent adhesion molecule intercellular adhesion molecule-
1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) expression [186, 187]. More 
recent data further indicate an involvement of the phosphatidylinositol 3-kinase 
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(PI3K)/AKT/Nrf2 signalling pathway in suppressing ROS/NF-B-mediated ICAM-1 and  
E-selectin expression in EA.hy926 ECs [188]. Although experimentally not addressed in 
the present investigation, it is tempting to assume that a modulation of NF-B activity and 
adhesion molecule expression contributes to the regulation of the adhesion process 
following ROS scavenging by NAC or activation of Nrf2 by AI-1 in EA.hy926 ECs. This 
hypothesis in addition is supported by previous data on a non-linear induction of NF-B 
DNA-binding and transcriptional activity and an altered surface expression of E-selectin to 
contribute to a reduced mononuclear cell adhesion in EA.hy926 ECs following 0.5 Gy 
irradiation [39, 42, 58]. Applying of DNA-binding and transcriptional activity assays after 
LD-RT was recently reported to result in a biphasic transcriptional activity of NF-B in 
stimulated EA.hy926 ECs at 24 h after irradiation with locally elevated values following an 
exposure of 0.5 Gy [58]. Moreover, NF-B activation has been shown to be regulated by 
ROS via both the classical (canonical) and the alternative pathways including atypical 
inhibitor Bα (IBα) phosphorylation independently of IB kinase (IKK) [189]. Although 
experimentally not proven at present, it is tempting to speculate that elevated levels of 
ROS at a dose of 0.5 Gy may contribute to an increased NF-B activity and as a 
consequence, to an increased secretion of the cytokine TGF-β1 [38, 42]. By using 
neutralising antibodies to TGF-β1, it was shown that TGF-β1 comprises a key component 
mediating the anti-adhesive efficacy of LD-RT [38, 42]. This assumption is further 
supported by a recent report indicating that ROS may comprise a regulator of adhesion 
molecules very late antigen-4 (VLA-4) and VCAM-1 mediated monocyte/macrophage 
adhesion to EC following irradiation with a dose of 0.5 Gy [190]. 
Finally, there is growing evidence on a tight crosstalk between the Nrf2 and NF-B 
pathway with both antagonistic and synergistic effects [191]. Whereas activation of Nrf2 
antioxidative signalling attenuates NF-B mediated inflammatory responses in a colorectal 
cancer model [192], NF-B signalling inhibits the Nrf2 pathway by a direct interaction of 
subunit p65 and Keap1 or a histone deacetylase 3 or CREB binding protein mediated 
transcriptional repression [193]. Thus, a more complex interrelationship of both NF-B and 
Nrf2 and regulation of corresponding targeted genes may contribute to a fine tuning of the 
adhesion process and the inflammation process in general, in EA.hy926 ECs following 
LD-RT. 
 
From a clinical point of view, the present experimental data highly support the preclinical 
observation that irradiation with single doses between 0.3 Gy and 1 Gy seem to be most 
effective for inducing anti-inflammatory responses. In line with that, a variety of recent 
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clinical investigations have indicated an isoeffective clinical response in patients with 
benign calcaneodynia, benign painful shoulder or painful elbow syndromes, when treated 
with a single fraction of 0.5 or 1 Gy while keeping the fractionation scheme [12, 64, 194]. 
These clinical results are the basis for dose reduction of LD-RT in the future clinical 
practice, which may contribute to a lowered carcinogenic radiation risk, while maintaining 
the beneficial effects associated with irradiation.  
 
 
Figure 17. Advanced model on factors involved in the anti-inflammatory effect of 
low-dose irradiation therapy 
Exposure of endothelial cells (ECs) to a dose of 0.5 Gy results in a modulation of antioxidative 
factors like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and 
transcription factor nuclear factor E2-related factor 2 (Nrf2) expression/activity resulting in 
increased reactive oxygen species (ROS) levels that functionally contributes to a hampered 
peripheral blood mononuclear cell (PBMC)/EC adhesion and increased levels of phospho-histone 
H2AX foci (H2AX). These effects may contribute to the anti-inflammatory impact of low-dose 
radiation therapy (LD-RT). IR: ionising radiation. 
 
In conclusion, data obtained during this dissertation revealed a discontinuous regulation of 
residual H2AX foci levels most prominent following irradiation with a dose of 0.5 Gy and a 
modulation of physiologic properties of ECs like leukocyte adhesion. A modulation of 
these processes include transcriptional mechanisms like Nrf2 mediated regulation of ROS 
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detoxifying enzymes (pictured in Figure 17) and putatively seems to be interconnected 
with the DNA damage response. Nevertheless, the exact impact of DNA repair 
mechanisms are not fully resolved at present. It is to assume that the discontinuous dose-
response curve and biphasic kinetics most likely originate from an overlay of various 
individual processes which are initiated at different thresholds, display different time 
kinetics, and operate in a staggered manner 
Although considerable progress has been achieved during the last two decades in the 
understanding of the molecular mechanisms being prominent after a low-dose exposure, 
still a multitude of unresolved questions exists, fostering further investigations. As 
inflammatory diseases are characterised by complex (patho-) physiological networks, 
ongoing research should focus on additional immunological mechanisms and cellular 
components and a differential regulation of ROS and their associated factors in other 
cellular systems and in appropriate preclinical animal models. Additionally, the kind, type 
and dosage of the stimulation may be varied in order to get more insight in the complex 
regulation of the anti-inflammatory effects of LD-RT. Moreover, getting closer to the daily 
clinical situation, effects of a fractionated radiation scheme and other radiation qualities 
(e.g. heavy ions) require further investigations. 
In the long run, these efforts will give extended insight in the radiobiology of low-dose 
radiation exposure and may help further to improve clinical radiation therapy of non-
malignant diseases.  
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Supplementary Figure 1. Dose and time kinetics of H2AX foci levels in 
EA.hy926 EC following low-dose X-irradiation divided into G1 and G2 phase 
EA.hy926 EC were plated onto coverslips and stimulated with TNF-α (20 ng/ml) (black bars) at 4 h 
before irradiation with the doses indicated. Mock-treated cells served as a control. At 1 h (A/B) and 
4 h (C/D) post irradiation, cells were fixed, stained for H2AX, DAPI and CENP-F and data of a total 
of 40 nuclei ((G1 phase (A/C/E) and G2 phase (B/D/F)) were evaluated. Data represent means 
± SEM from at least three independent experiments. *p < 0.05. 
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Own work 
Experiments, data analysis and writing of the present thesis with exception of the following 
items, were all done by myself. 
The activity assays in Figure 10 and Figure 11 were done by Dr. Sebastian Reichert 
(Department of Radiotherapy and Oncology, University of Frankfurt am Main, Germany). 
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Abbreviation Full name 
H2AX histone H2A, member X 
µg microgram 
µl microliter 
µm micrometre 
µM micromolar 
53BP1 p53-binding protein 1 
5-OH-MeHyd 5-hydroxy-5-methylhydantoin 
5-OH-Me-Ura 5-hydroxymethyluracil 
8-OH-dG 8-oxoguanine 
AP-1 Activator protein 1 
ARE Antioxidant response element 
ATM Ataxia telangiectasia mutated 
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BRAF proto-oncogene B-Raf 
BRCA1 Breast cancer 1 
BRCA2 Breast cancer type 2 susceptibility protein 
BSA Bovine serum albumin 
TAMRA Carboxytetramethylrhodamine 
CAT Catalase 
CDK1 Cyclin-dependent kinase 1 
CENP-F Centromere protein-F 
CIN Chromosomal instability 
CK2  Casein kinase 2 
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CO2 Carbon dioxide 
COPD Chronic obstructive pulmonary disease 
CPS Comprehensive pain score 
CtiP CtBP-interacting protein 
Cul3 Cullin-3 
DAPI 4',6-diamidino-2-phenylindole 
DMEM Dulbecco’s Modified Eagle Medium 
DNA Deoxyribonucleic acid 
DNA DSBs DNA Double-strand breaks 
DNA-PKcs DNA-dependent protein kinase, catalytic 
subunit 
DSB DNA double-strand break 
EC Endothelial cell 
ECL Enhanced chemiluminescence 
EDTA Ethylenediaminetetraacetic acid 
Exo1 Exonuclease 1 
FACS Fluorescence-activated cell sorting 
G2 Gap 2 phase (of the cell cycle) 
GPx Glutathione-peroxidase 
GR Glutathione reductase 
GSH Glutathione 
GSSG Glutathione disulphide 
GTP-binding protein Guanosine nucleotide-binding protein 
H2DCFDA 2′ ,7′ -dichlorodihydrofluoresceindiacetate 
H2O2 Hydrogen peroxide 
HO-1 Heme oxygenase 1 
HR Homologous recombination 
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HRP Horseradish peroxidase 
HRS  Hyper-radiosensitivity 
hSSB1 Human single stranded binding protein-1 
ICAM-1 Intercellular adhesion molecule 1 
ICAM-2 Intercellular adhesion molecule 2 
IF Immunofluorescence 
IgG Immunoglobulin G 
IKK IκB kinase 
IL Interleukin 
iNOS Inducible nitric oxide synthases 
IR Ionizing radiation 
IRR Induced radioresistance 
IκBα Inhibitor κBα 
Keap1 Kelch-like ECH-associated protein 
LD-RT Low-dose radiation therapy 
MAPK Mitogen-activated protein kinase 
MCP1 Monocyte chemoattractant protein-1 
MDC1 Mediator of DNA damage checkpoint 
protein 1 
MMR Mismatch repair 
MRE11 Meiotic recombination 11 homolog 
mRNA Messenger RNA 
MRN-complex Mre11, Rad50 and Nbs1 complex 
NADPH Nicotinamide adenine dinucleotide 
phosphate 
NF-B nuclear factor kappa-light-chain-enhancer 
of activated B cells 
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NHEJ Non-homologous end joining 
NK Natural killer 
NOX NADPH oxidase 
Nrf2 Nuclear factor erythroid 2-related factor 2 
O2-• Superoxide 
OH• Hydroxyl radical 
ONOO− Peroxynitrite 
PA Polyarthritis 
PBMC Peripheral blood mononuclear cells 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
PIKK Phosphatidylinositol 3-kinase-related 
kinases 
PMA Phorbol myristate acetate 
PMN Polymorph nuclear cells 
qPCR Real-time/quantitative polymerase chain 
reaction 
Ras-related C3 botulinum toxin substrate 
1 
Rac1 
RIPA Radioimmunoprecipitation assay buffer 
ROS Reactive oxygen species 
RPA Replication protein A 
RT Room temperature 
SDS Sodium dodecylsulfate 
SEM Standard error of the mean 
SOD Superoxide dismutase 
ssDNA Single stranded DNA 
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TAE buffer Tris-Acetate-EDTA buffer 
TBS buffer Tris-buffered saline 
TGF-β Transforming growth factor beta 
TNF-α Tumour necrosis factor alpha 
TRIS Tris hydroxymethyl aminomethane 
VCAM-1 Vascular cell adhesion molecule 
VLA-4 Very late antigen-4 
XIAP X-chromosome linked inhibitor of apoptosis 
protein 
XO Xanthine oxidase 
XRCC4 X-ray repair cross-complementing protein 4 
 
